 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0004823	leucine-tRNA ligase activity	1	2.160879e-4	7.969322e-1	7.969322e-1	4.627746e+3	2.160879e-4	1	2.160879e-4	1.000000e+0	1	2.217111e-4	8.176705e-1	8.176705e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	LARS2
GO Molecular Function	GO:0002161	aminoacyl-tRNA editing activity	2	3.788587e-4	1.000000e+0	6.986154e-1	2.639507e+3	3.788587e-4	1	3.788587e-4	1.000000e+0	2	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	LARS2
GO Molecular Function	GO:0004812	aminoacyl-tRNA ligase activity	3	2.798068e-3	1.000000e+0	1.000000e+0	3.573895e+2	2.798068e-3	1	2.798068e-3	1.000000e+0	3	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	LARS2
GO Molecular Function	GO:0052689	carboxylic ester hydrolase activity	4	6.575470e-3	1.000000e+0	1.000000e+0	1.520804e+2	6.575470e-3	1	6.575470e-3	1.000000e+0	4	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	LARS2
GO Molecular Function	GO:0042277	peptide binding	5	1.583040e-2	1.000000e+0	1.000000e+0	6.316962e+1	1.583040e-2	1	1.583040e-2	1.000000e+0	5	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	TMEM158
GO Molecular Function	GO:0033218	amide binding	6	1.625719e-2	1.000000e+0	1.000000e+0	6.151126e+1	1.625719e-2	1	1.625719e-2	1.000000e+0	6	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	TMEM158
GO Molecular Function	GO:0016874	ligase activity	7	4.606981e-2	1.000000e+0	1.000000e+0	2.170619e+1	4.606981e-2	1	4.606981e-2	1.000000e+0	7	5.433930e-2	1.000000e+0	1.000000e+0	1.814990e+1	5.509672e-2	1	497	5.000000e-1	2.012072e-3	unnamed	LARS2
GO Molecular Function	GO:0016788	hydrolase activity, acting on ester bonds	8	6.759571e-2	1.000000e+0	1.000000e+0	1.479384e+1	6.759571e-2	1	6.759571e-2	1.000000e+0	8	8.226776e-2	1.000000e+0	1.000000e+0	1.190040e+1	8.403082e-2	1	758	5.000000e-1	1.319261e-3	unnamed	LARS2
GO Molecular Function	GO:0005524	ATP binding	9	1.376192e-1	1.000000e+0	1.000000e+0	7.266427e+0	1.376192e-1	1	1.376192e-1	1.000000e+0	9	1.563271e-1	1.000000e+0	1.000000e+0	6.136395e+0	1.629621e-1	1	1470	5.000000e-1	6.802721e-4	unnamed	LARS2
GO Molecular Function	GO:0032559	adenyl ribonucleotide binding	10	1.426806e-1	1.000000e+0	1.000000e+0	7.008664e+0	1.426806e-1	1	1.426806e-1	1.000000e+0	10	1.595825e-1	1.000000e+0	1.000000e+0	6.005659e+0	1.665096e-1	1	1502	5.000000e-1	6.657790e-4	unnamed	LARS2
GO Molecular Function	GO:0030554	adenyl nucleotide binding	11	1.431520e-1	1.000000e+0	1.000000e+0	6.985581e+0	1.431520e-1	1	1.431520e-1	1.000000e+0	11	1.611063e-1	1.000000e+0	1.000000e+0	5.946276e+0	1.681725e-1	1	1517	5.000000e-1	6.591958e-4	unnamed	LARS2
GO Molecular Function	GO:0035639	purine ribonucleoside triphosphate binding	12	1.642264e-1	1.000000e+0	1.000000e+0	6.089156e+0	1.642264e-1	1	1.642264e-1	1.000000e+0	12	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	LARS2
GO Molecular Function	GO:0032550	purine ribonucleoside binding	13	1.650919e-1	1.000000e+0	1.000000e+0	6.057234e+0	1.650919e-1	1	1.650919e-1	1.000000e+0	13	1.911919e-1	1.000000e+0	1.000000e+0	4.967236e+0	2.013192e-1	1	1816	5.000000e-1	5.506608e-4	unnamed	LARS2
GO Molecular Function	GO:0001883	purine nucleoside binding	14	1.651911e-1	1.000000e+0	1.000000e+0	6.053594e+0	1.651911e-1	1	1.651911e-1	1.000000e+0	14	1.914910e-1	1.000000e+0	1.000000e+0	4.959043e+0	2.016518e-1	1	1819	5.000000e-1	5.497526e-4	unnamed	LARS2
GO Molecular Function	GO:0032549	ribonucleoside binding	15	1.652867e-1	1.000000e+0	1.000000e+0	6.050092e+0	1.652867e-1	1	1.652867e-1	1.000000e+0	15	1.915906e-1	1.000000e+0	1.000000e+0	4.956319e+0	2.017627e-1	1	1820	5.000000e-1	5.494505e-4	unnamed	LARS2
GO Molecular Function	GO:0001882	nucleoside binding	16	1.658155e-1	1.000000e+0	1.000000e+0	6.030800e+0	1.658155e-1	1	1.658155e-1	1.000000e+0	16	1.925871e-1	1.000000e+0	1.000000e+0	4.929235e+0	2.028712e-1	1	1830	5.000000e-1	5.464481e-4	unnamed	LARS2
GO Molecular Function	GO:0032555	purine ribonucleotide binding	17	1.693981e-1	1.000000e+0	1.000000e+0	5.903255e+0	1.693981e-1	1	1.693981e-1	1.000000e+0	17	1.940807e-1	1.000000e+0	1.000000e+0	4.889160e+0	2.045341e-1	1	1845	5.000000e-1	5.420054e-4	unnamed	LARS2
GO Molecular Function	GO:0017076	purine nucleotide binding	18	1.701196e-1	1.000000e+0	1.000000e+0	5.878217e+0	1.701196e-1	1	1.701196e-1	1.000000e+0	19	1.957717e-1	1.000000e+0	1.000000e+0	4.844522e+0	2.064187e-1	1	1862	5.000000e-1	5.370569e-4	unnamed	LARS2
GO Molecular Function	GO:0032553	ribonucleotide binding	19	1.708664e-1	1.000000e+0	1.000000e+0	5.852525e+0	1.708664e-1	1	1.708664e-1	1.000000e+0	18	1.954734e-1	1.000000e+0	1.000000e+0	4.852340e+0	2.060861e-1	1	1859	5.000000e-1	5.379236e-4	unnamed	LARS2
GO Molecular Function	GO:0016787	hydrolase activity	20	1.965374e-1	1.000000e+0	1.000000e+0	5.088091e+0	1.965374e-1	1	1.965374e-1	1.000000e+0	23	2.486583e-1	1.000000e+0	1.000000e+0	3.753849e+0	2.663932e-1	1	2403	5.000000e-1	4.161465e-4	unnamed	LARS2
GO Molecular Function	GO:0097367	carbohydrate derivative binding	21	1.996235e-1	1.000000e+0	1.000000e+0	5.009431e+0	1.996235e-1	1	1.996235e-1	1.000000e+0	20	2.230751e-1	1.000000e+0	1.000000e+0	4.217158e+0	2.371265e-1	1	2139	5.000000e-1	4.675082e-4	unnamed	LARS2
GO Molecular Function	GO:0000166	nucleotide binding	22	2.080686e-1	1.000000e+0	1.000000e+0	4.806107e+0	2.080686e-1	1	2.080686e-1	1.000000e+0	21	2.401781e-1	1.000000e+0	1.000000e+0	3.896544e+0	2.566377e-1	1	2315	5.000000e-1	4.319654e-4	unnamed	LARS2
GO Molecular Function	GO:1901265	nucleoside phosphate binding	23	2.081652e-1	1.000000e+0	1.000000e+0	4.803877e+0	2.081652e-1	1	2.081652e-1	1.000000e+0	22	2.402748e-1	1.000000e+0	1.000000e+0	3.894862e+0	2.567485e-1	1	2316	5.000000e-1	4.317789e-4	unnamed	LARS2
GO Molecular Function	GO:0036094	small molecule binding	24	2.286651e-1	1.000000e+0	1.000000e+0	4.373209e+0	2.286651e-1	1	2.286651e-1	1.000000e+0	24	2.643352e-1	1.000000e+0	1.000000e+0	3.514024e+0	2.845740e-1	1	2567	5.000000e-1	3.895598e-4	unnamed	LARS2
GO Molecular Function	GO:0043168	anion binding	25	2.579088e-1	1.000000e+0	1.000000e+0	3.877340e+0	2.579088e-1	1	2.579088e-1	1.000000e+0	25	2.792822e-1	1.000000e+0	1.000000e+0	3.310275e+0	3.020897e-1	1	2725	5.000000e-1	3.669725e-4	unnamed	LARS2
GO Molecular Function	GO:1901363	heterocyclic compound binding	26	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	27	5.012582e-1	1.000000e+0	1.000000e+0	1.701981e+0	5.875506e-1	1	5300	5.000000e-1	1.886792e-4	unnamed	LARS2
GO Molecular Function	GO:0097159	organic cyclic compound binding	27	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	28	5.069571e-1	1.000000e+0	1.000000e+0	1.678857e+0	5.956433e-1	1	5373	5.000000e-1	1.861158e-4	unnamed	LARS2
GO Molecular Function	GO:0003824	catalytic activity	28	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	29	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	LARS2
GO Molecular Function	GO:0043167	ion binding	29	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	30	5.570694e-1	1.000000e+0	1.000000e+0	1.494945e+0	6.689208e-1	1	6034	5.000000e-1	1.657275e-4	unnamed	LARS2
GO Molecular Function	GO:0005488	binding	30	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	26	4.553379e-1	1.000000e+0	1.000000e+0	1.481929e+0	1.349593e+0	2	12174	1.000000e+0	1.642845e-4	unnamed	LARS2,TMEM158
GO Biological Process	GO:0006429	leucyl-tRNA aminoacylation	1	2.160879e-4	1.000000e+0	1.000000e+0	4.627746e+3	2.160879e-4	1	2.160879e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	LARS2
GO Biological Process	GO:0006450	regulation of translational fidelity	2	3.901167e-4	1.000000e+0	1.000000e+0	2.563336e+3	3.901167e-4	1	3.901167e-4	1.000000e+0	2	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	LARS2
GO Biological Process	GO:0006448	regulation of translational elongation	3	1.111514e-3	1.000000e+0	1.000000e+0	8.996740e+2	1.111514e-3	1	1.111514e-3	1.000000e+0	3	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	LARS2
GO Biological Process	GO:0006418	tRNA aminoacylation for protein translation	4	3.234028e-3	1.000000e+0	1.000000e+0	3.092119e+2	3.234028e-3	1	3.234028e-3	1.000000e+0	4	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	LARS2
GO Biological Process	GO:0043039	tRNA aminoacylation	5	3.776533e-3	1.000000e+0	1.000000e+0	2.647931e+2	3.776533e-3	1	3.776533e-3	1.000000e+0	5	5.756499e-3	1.000000e+0	1.000000e+0	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	LARS2
GO Biological Process	GO:0006399	tRNA metabolic process	6	8.440032e-3	1.000000e+0	1.000000e+0	1.184830e+2	8.440032e-3	1	8.440032e-3	1.000000e+0	6	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	LARS2
GO Biological Process	GO:0034660	ncRNA metabolic process	7	1.918569e-2	1.000000e+0	1.000000e+0	5.212218e+1	1.918569e-2	1	1.918569e-2	1.000000e+0	8	3.450762e-2	1.000000e+0	1.000000e+0	2.872771e+1	3.480960e-2	1	314	5.000000e-1	3.184713e-3	unnamed	LARS2
GO Biological Process	GO:0006417	regulation of translation	8	1.925828e-2	1.000000e+0	1.000000e+0	5.192570e+1	1.925828e-2	1	1.925828e-2	1.000000e+0	7	2.664858e-2	1.000000e+0	1.000000e+0	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	LARS2
GO Biological Process	GO:0006412	translation	9	2.132101e-2	1.000000e+0	1.000000e+0	4.690208e+1	2.132101e-2	1	2.132101e-2	1.000000e+0	9	3.962064e-2	1.000000e+0	1.000000e+0	2.498753e+1	4.001995e-2	1	361	5.000000e-1	2.770083e-3	unnamed	LARS2
GO Biological Process	GO:0006520	cellular amino acid metabolic process	10	3.348268e-2	1.000000e+0	1.000000e+0	2.986619e+1	3.348268e-2	1	3.348268e-2	1.000000e+0	11	4.515346e-2	1.000000e+0	1.000000e+0	2.189442e+1	4.567374e-2	1	412	5.000000e-1	2.427184e-3	unnamed	LARS2
GO Biological Process	GO:0010608	posttranscriptional regulation of gene expression	11	3.378331e-2	1.000000e+0	1.000000e+0	2.960041e+1	3.378331e-2	1	3.378331e-2	1.000000e+0	10	4.374465e-2	1.000000e+0	1.000000e+0	2.260777e+1	4.423258e-2	1	399	5.000000e-1	2.506266e-3	unnamed	LARS2
GO Biological Process	GO:0019752	carboxylic acid metabolic process	12	6.544102e-2	1.000000e+0	1.000000e+0	1.528093e+1	6.544102e-2	1	6.544102e-2	1.000000e+0	12	8.735845e-2	1.000000e+0	1.000000e+0	1.119169e+1	8.935203e-2	1	806	5.000000e-1	1.240695e-3	unnamed	LARS2
GO Biological Process	GO:0043436	oxoacid metabolic process	13	8.179018e-2	1.000000e+0	1.000000e+0	1.222641e+1	8.179018e-2	1	8.179018e-2	1.000000e+0	13	9.918168e-2	1.000000e+0	1.000000e+0	9.826253e+0	1.017682e-1	1	918	5.000000e-1	1.089325e-3	unnamed	LARS2
GO Biological Process	GO:0006082	organic acid metabolic process	14	8.296012e-2	1.000000e+0	1.000000e+0	1.205398e+1	8.296012e-2	1	8.296012e-2	1.000000e+0	14	1.008644e-1	1.000000e+0	1.000000e+0	9.657923e+0	1.035419e-1	1	934	5.000000e-1	1.070664e-3	unnamed	LARS2
GO Biological Process	GO:1901564	organonitrogen compound metabolic process	15	1.379740e-1	1.000000e+0	1.000000e+0	7.247740e+0	1.379740e-1	1	1.379740e-1	1.000000e+0	16	1.637442e-1	1.000000e+0	1.000000e+0	5.846079e+0	1.710548e-1	1	1543	5.000000e-1	6.480881e-4	unnamed	LARS2
GO Biological Process	GO:0032268	regulation of cellular protein metabolic process	16	1.389785e-1	1.000000e+0	1.000000e+0	7.195356e+0	1.389785e-1	1	1.389785e-1	1.000000e+0	15	1.498997e-1	1.000000e+0	1.000000e+0	6.411158e+0	1.559780e-1	1	1407	5.000000e-1	7.107321e-4	unnamed	LARS2
GO Biological Process	GO:0051246	regulation of protein metabolic process	17	1.559232e-1	1.000000e+0	1.000000e+0	6.413414e+0	1.559232e-1	1	1.559232e-1	1.000000e+0	17	1.698159e-1	1.000000e+0	1.000000e+0	5.627261e+0	1.777063e-1	1	1603	5.000000e-1	6.238303e-4	unnamed	LARS2
GO Biological Process	GO:0044281	small molecule metabolic process	18	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	18	2.509628e-1	1.000000e+0	1.000000e+0	3.716728e+0	2.690538e-1	1	2427	5.000000e-1	4.120313e-4	unnamed	LARS2
GO Biological Process	GO:0044710	single-organism metabolic process	19	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	21	3.105584e-1	1.000000e+0	1.000000e+0	2.946913e+0	3.393382e-1	1	3061	5.000000e-1	3.266906e-4	unnamed	LARS2
GO Biological Process	GO:0044267	cellular protein metabolic process	20	2.533433e-1	1.000000e+0	1.000000e+0	3.947214e+0	2.533433e-1	1	2.533433e-1	1.000000e+0	20	2.989111e-1	1.000000e+0	1.000000e+0	3.073424e+0	3.253700e-1	1	2935	5.000000e-1	3.407155e-4	unnamed	LARS2
GO Biological Process	GO:0016070	RNA metabolic process	21	2.686590e-1	1.000000e+0	1.000000e+0	3.722190e+0	2.686590e-1	1	2.686590e-1	1.000000e+0	22	3.211950e-1	1.000000e+0	1.000000e+0	2.839314e+0	3.521978e-1	1	3177	5.000000e-1	3.147624e-4	unnamed	LARS2
GO Biological Process	GO:0065008	regulation of biological quality	22	2.713082e-1	1.000000e+0	1.000000e+0	3.685845e+0	2.713082e-1	1	2.713082e-1	1.000000e+0	19	2.887566e-1	1.000000e+0	1.000000e+0	3.191967e+0	3.132864e-1	1	2826	5.000000e-1	3.538570e-4	unnamed	LARS2
GO Biological Process	GO:0010467	gene expression	23	2.836887e-1	1.000000e+0	1.000000e+0	3.524990e+0	2.836887e-1	1	2.836887e-1	1.000000e+0	25	3.441967e-1	1.000000e+0	1.000000e+0	2.629117e+0	3.803559e-1	1	3431	5.000000e-1	2.914602e-4	unnamed	LARS2
GO Biological Process	GO:0034645	cellular macromolecule biosynthetic process	24	2.892943e-1	1.000000e+0	1.000000e+0	3.456687e+0	2.892943e-1	1	2.892943e-1	1.000000e+0	23	3.331981e-1	1.000000e+0	1.000000e+0	2.726050e+0	3.668311e-1	1	3309	5.000000e-1	3.022061e-4	unnamed	LARS2
GO Biological Process	GO:0009059	macromolecule biosynthetic process	25	2.955002e-1	1.000000e+0	1.000000e+0	3.384092e+0	2.955002e-1	1	2.955002e-1	1.000000e+0	24	3.377168e-1	1.000000e+0	1.000000e+0	2.685472e+0	3.723740e-1	1	3359	5.000000e-1	2.977077e-4	unnamed	LARS2
GO Biological Process	GO:0019538	protein metabolic process	26	2.975455e-1	1.000000e+0	1.000000e+0	3.360830e+0	2.975455e-1	1	2.975455e-1	1.000000e+0	26	3.508235e-1	1.000000e+0	1.000000e+0	2.573609e+0	3.885594e-1	1	3505	5.000000e-1	2.853067e-4	unnamed	LARS2
GO Biological Process	GO:0090304	nucleic acid metabolic process	27	3.065231e-1	1.000000e+0	1.000000e+0	3.262397e+0	3.065231e-1	1	3.065231e-1	1.000000e+0	32	3.768188e-1	1.000000e+0	1.000000e+0	2.374441e+0	4.211518e-1	1	3799	5.000000e-1	2.632272e-4	unnamed	LARS2
GO Biological Process	GO:2000112	regulation of cellular macromolecule biosynthetic process	28	3.236874e-1	1.000000e+0	1.000000e+0	3.089400e+0	3.236874e-1	1	3.236874e-1	1.000000e+0	26	3.508235e-1	1.000000e+0	1.000000e+0	2.573609e+0	3.885594e-1	1	3505	5.000000e-1	2.853067e-4	unnamed	LARS2
GO Biological Process	GO:0010556	regulation of macromolecule biosynthetic process	29	3.285042e-1	1.000000e+0	1.000000e+0	3.044101e+0	3.285042e-1	1	3.285042e-1	1.000000e+0	28	3.578608e-1	1.000000e+0	1.000000e+0	2.516881e+0	3.973172e-1	1	3584	5.000000e-1	2.790179e-4	unnamed	LARS2
GO Biological Process	GO:0031326	regulation of cellular biosynthetic process	30	3.434354e-1	1.000000e+0	1.000000e+0	2.911756e+0	3.434354e-1	1	3.434354e-1	1.000000e+0	29	3.710294e-1	1.000000e+0	1.000000e+0	2.416421e+0	4.138352e-1	1	3733	5.000000e-1	2.678811e-4	unnamed	LARS2
GO Biological Process	GO:0010468	regulation of gene expression	31	3.434880e-1	1.000000e+0	1.000000e+0	2.911310e+0	3.434880e-1	1	3.434880e-1	1.000000e+0	30	3.723475e-1	1.000000e+0	1.000000e+0	2.406750e+0	4.154980e-1	1	3748	5.000000e-1	2.668090e-4	unnamed	LARS2
GO Biological Process	GO:0009889	regulation of biosynthetic process	32	3.455319e-1	1.000000e+0	1.000000e+0	2.894089e+0	3.455319e-1	1	3.455319e-1	1.000000e+0	31	3.736643e-1	1.000000e+0	1.000000e+0	2.397157e+0	4.171609e-1	1	3763	5.000000e-1	2.657454e-4	unnamed	LARS2
GO Biological Process	GO:0044249	cellular biosynthetic process	33	3.470471e-1	1.000000e+0	1.000000e+0	2.881453e+0	3.470471e-1	1	3.470471e-1	1.000000e+0	33	4.041671e-1	1.000000e+0	1.000000e+0	2.192102e+0	4.561831e-1	1	4115	5.000000e-1	2.430134e-4	unnamed	LARS2
GO Biological Process	GO:0006139	nucleobase-containing compound metabolic process	34	3.530780e-1	1.000000e+0	1.000000e+0	2.832235e+0	3.530780e-1	1	3.530780e-1	1.000000e+0	36	4.351591e-1	1.000000e+0	1.000000e+0	2.012606e+0	4.968682e-1	1	4482	5.000000e-1	2.231147e-4	unnamed	LARS2
GO Biological Process	GO:1901576	organic substance biosynthetic process	35	3.536536e-1	1.000000e+0	1.000000e+0	2.827626e+0	3.536536e-1	1	3.536536e-1	1.000000e+0	34	4.118439e-1	1.000000e+0	1.000000e+0	2.145184e+0	4.661604e-1	1	4205	5.000000e-1	2.378121e-4	unnamed	LARS2
GO Biological Process	GO:0009058	biosynthetic process	36	3.586722e-1	1.000000e+0	1.000000e+0	2.788061e+0	3.586722e-1	1	3.586722e-1	1.000000e+0	35	4.178650e-1	1.000000e+0	1.000000e+0	2.109565e+0	4.740314e-1	1	4276	5.000000e-1	2.338634e-4	unnamed	LARS2
GO Biological Process	GO:0046483	heterocycle metabolic process	37	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	38	4.495636e-1	1.000000e+0	1.000000e+0	1.937393e+0	5.161576e-1	1	4656	5.000000e-1	2.147766e-4	unnamed	LARS2
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	38	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	39	4.506323e-1	1.000000e+0	1.000000e+0	1.931998e+0	5.175988e-1	1	4669	5.000000e-1	2.141786e-4	unnamed	LARS2
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	39	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	40	4.663767e-1	1.000000e+0	1.000000e+0	1.855306e+0	5.389945e-1	1	4862	5.000000e-1	2.056767e-4	unnamed	LARS2
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	40	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	41	4.683993e-1	1.000000e+0	1.000000e+0	1.845815e+0	5.417660e-1	1	4887	5.000000e-1	2.046245e-4	unnamed	LARS2
GO Biological Process	GO:0060255	regulation of macromolecule metabolic process	41	4.100897e-1	1.000000e+0	1.000000e+0	2.438491e+0	4.100897e-1	1	4.100897e-1	1.000000e+0	37	4.477526e-1	1.000000e+0	1.000000e+0	1.946590e+0	5.137188e-1	1	4634	5.000000e-1	2.157963e-4	unnamed	LARS2
GO Biological Process	GO:0006807	nitrogen compound metabolic process	42	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	44	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	LARS2
GO Biological Process	GO:0080090	regulation of primary metabolic process	43	4.363900e-1	1.000000e+0	1.000000e+0	2.291528e+0	4.363900e-1	1	4.363900e-1	1.000000e+0	42	4.714664e-1	1.000000e+0	1.000000e+0	1.831574e+0	5.459786e-1	1	4925	5.000000e-1	2.030457e-4	unnamed	LARS2
GO Biological Process	GO:0031323	regulation of cellular metabolic process	44	4.406599e-1	1.000000e+0	1.000000e+0	2.269324e+0	4.406599e-1	1	4.406599e-1	1.000000e+0	43	4.760505e-1	1.000000e+0	1.000000e+0	1.810618e+0	5.522975e-1	1	4982	5.000000e-1	2.007226e-4	unnamed	LARS2
GO Biological Process	GO:0019222	regulation of metabolic process	45	4.728179e-1	1.000000e+0	1.000000e+0	2.114979e+0	4.728179e-1	1	4.728179e-1	1.000000e+0	45	5.177180e-1	1.000000e+0	1.000000e+0	1.636520e+0	6.110526e-1	1	5512	5.000000e-1	1.814224e-4	unnamed	LARS2
GO Biological Process	GO:0044260	cellular macromolecule metabolic process	46	4.901841e-1	1.000000e+0	1.000000e+0	2.040050e+0	4.901841e-1	1	4.901841e-1	1.000000e+0	46	5.672657e-1	1.000000e+0	1.000000e+0	1.461283e+0	6.843301e-1	1	6173	5.000000e-1	1.619958e-4	unnamed	LARS2
GO Biological Process	GO:0043170	macromolecule metabolic process	47	5.266956e-1	1.000000e+0	1.000000e+0	1.898630e+0	5.266956e-1	1	5.266956e-1	1.000000e+0	47	6.104699e-1	1.000000e+0	1.000000e+0	1.330261e+0	7.517322e-1	1	6781	5.000000e-1	1.474709e-4	unnamed	LARS2
GO Biological Process	GO:0044237	cellular metabolic process	48	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	48	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	LARS2
GO Biological Process	GO:0044238	primary metabolic process	49	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	49	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	LARS2
GO Biological Process	GO:0071704	organic substance metabolic process	50	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	50	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	LARS2
GO Biological Process	GO:0008152	metabolic process	51	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	52	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	LARS2
GO Biological Process	GO:0050794	regulation of cellular process	52	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	51	7.406997e-1	1.000000e+0	1.000000e+0	1.018805e+0	9.815420e-1	1	8854	5.000000e-1	1.129433e-4	unnamed	LARS2
GO Biological Process	GO:0050789	regulation of biological process	53	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	53	7.668214e-1	1.000000e+0	1.000000e+0	9.669311e-1	1.034200e+0	1	9329	5.000000e-1	1.071926e-4	unnamed	LARS2
GO Biological Process	GO:0065007	biological regulation	54	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	54	7.940293e-1	1.000000e+0	1.000000e+0	9.155080e-1	1.092290e+0	1	9853	5.000000e-1	1.014919e-4	unnamed	LARS2
GO Biological Process	GO:0009987	cellular process	55	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	55	9.369062e-1	1.000000e+0	1.000000e+0	6.677400e-1	1.497589e+0	1	13509	5.000000e-1	7.402472e-5	unnamed	LARS2
GO Cellular Component	GO:0005759	mitochondrial matrix	1	2.150026e-2	1.000000e+0	1.000000e+0	4.651106e+1	2.150026e-2	1	2.150026e-2	1.000000e+0	1	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	LARS2
GO Cellular Component	GO:0044429	mitochondrial part	2	5.499540e-2	1.000000e+0	1.000000e+0	1.818334e+1	5.499540e-2	1	5.499540e-2	1.000000e+0	2	8.598112e-2	1.000000e+0	1.000000e+0	1.137516e+1	8.791087e-2	1	793	5.000000e-1	1.261034e-3	unnamed	LARS2
GO Cellular Component	GO:0005739	mitochondrion	3	1.171632e-1	1.000000e+0	1.000000e+0	8.535104e+0	1.171632e-1	1	1.171632e-1	1.000000e+0	3	1.680979e-1	1.000000e+0	1.000000e+0	5.687579e+0	1.758217e-1	1	1586	5.000000e-1	6.305170e-4	unnamed	LARS2
GO Cellular Component	GO:0070013	intracellular organelle lumen	4	2.178720e-1	1.000000e+0	1.000000e+0	4.589852e+0	2.178720e-1	1	2.178720e-1	1.000000e+0	4	2.759844e-1	1.000000e+0	1.000000e+0	3.353346e+0	2.982096e-1	1	2690	5.000000e-1	3.717472e-4	unnamed	LARS2
GO Cellular Component	GO:0043233	organelle lumen	5	2.231770e-1	1.000000e+0	1.000000e+0	4.480748e+0	2.231770e-1	1	2.231770e-1	1.000000e+0	5	2.816332e-1	1.000000e+0	1.000000e+0	3.280182e+0	3.048611e-1	1	2750	5.000000e-1	3.636364e-4	unnamed	LARS2
GO Cellular Component	GO:0031974	membrane-enclosed lumen	6	2.255118e-1	1.000000e+0	1.000000e+0	4.434357e+0	2.255118e-1	1	2.255118e-1	1.000000e+0	6	2.863237e-1	1.000000e+0	1.000000e+0	3.221607e+0	3.104041e-1	1	2800	5.000000e-1	3.571429e-4	unnamed	LARS2
GO Cellular Component	GO:0016021	integral to membrane	7	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	7	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	TMEM158
GO Cellular Component	GO:0031224	intrinsic to membrane	8	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	8	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	TMEM158
GO Cellular Component	GO:0044446	intracellular organelle part	9	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	10	5.897910e-1	1.000000e+0	1.000000e+0	1.390765e+0	7.190289e-1	1	6486	5.000000e-1	1.541782e-4	unnamed	LARS2
GO Cellular Component	GO:0044422	organelle part	10	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	11	5.977049e-1	1.000000e+0	1.000000e+0	1.367157e+0	7.314450e-1	1	6598	5.000000e-1	1.515611e-4	unnamed	LARS2
GO Cellular Component	GO:0044444	cytoplasmic part	11	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	12	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	LARS2
GO Cellular Component	GO:0044425	membrane part	12	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	9	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	TMEM158
GO Cellular Component	GO:0016020	membrane	13	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	13	6.811747e-1	1.000000e+0	1.000000e+0	1.148523e+0	8.706834e-1	1	7854	5.000000e-1	1.273237e-4	unnamed	TMEM158
GO Cellular Component	GO:0005737	cytoplasm	14	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	14	7.735178e-1	1.000000e+0	1.000000e+0	9.540455e-1	1.048168e+0	1	9455	5.000000e-1	1.057641e-4	unnamed	LARS2
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	15	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	15	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	LARS2
GO Cellular Component	GO:0043227	membrane-bounded organelle	16	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	16	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	LARS2
GO Cellular Component	GO:0043229	intracellular organelle	17	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	17	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	LARS2
GO Cellular Component	GO:0043226	organelle	18	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	18	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	LARS2
GO Cellular Component	GO:0044424	intracellular part	19	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	19	9.083176e-1	1.000000e+0	1.000000e+0	7.171649e-1	1.394379e+0	1	12578	5.000000e-1	7.950390e-5	unnamed	LARS2
GO Cellular Component	GO:0005622	intracellular	20	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	20	9.139354e-1	1.000000e+0	1.000000e+0	7.076012e-1	1.413225e+0	1	12748	5.000000e-1	7.844368e-5	unnamed	LARS2
GO Cellular Component	GO:0044464	cell part	21	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	21	9.677154e-1	1.000000e+0	1.000000e+0	6.095344e-1	1.640596e+0	1	14799	5.000000e-1	6.757213e-5	unnamed	LARS2
GO Cellular Component	GO:0005623	cell	22	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	22	9.677354e-1	1.000000e+0	1.000000e+0	6.094932e-1	1.640707e+0	1	14800	5.000000e-1	6.756757e-5	unnamed	LARS2
Human Phenotype	HP:0008209	Premature ovarian failure	1	1.760722e-3	1.000000e+0	1.000000e+0	5.679489e+2	1.760722e-3	1	1.760722e-3	1.000000e+0	1	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	LARS2
Human Phenotype	HP:0001730	Progressive hearing impairment	2	1.839342e-3	1.000000e+0	1.000000e+0	5.436728e+2	1.839342e-3	1	1.839342e-3	1.000000e+0	2	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	LARS2
Human Phenotype	HP:0000869	Secondary amenorrhea	3	1.867454e-3	1.000000e+0	1.000000e+0	5.354884e+2	1.867454e-3	1	1.867454e-3	1.000000e+0	3	2.105263e-3	1.000000e+0	1.000000e+0	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	LARS2
Human Phenotype	HP:0000657	Oculomotor apraxia	4	2.502148e-3	1.000000e+0	1.000000e+0	3.996566e+2	2.502148e-3	1	2.502148e-3	1.000000e+0	4	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	LARS2
Human Phenotype	HP:0002186	Apraxia	5	4.874832e-3	1.000000e+0	1.000000e+0	2.051353e+2	4.874832e-3	1	4.874832e-3	1.000000e+0	6	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	LARS2
Human Phenotype	HP:0000762	Decreased nerve conduction velocity	6	6.308917e-3	1.000000e+0	1.000000e+0	1.585058e+2	6.308917e-3	1	6.308917e-3	1.000000e+0	9	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	LARS2
Human Phenotype	HP:0000147	Polycystic ovaries	7	6.605624e-3	1.000000e+0	1.000000e+0	1.513861e+2	6.605624e-3	1	6.605624e-3	1.000000e+0	5	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	LARS2
Human Phenotype	HP:0003134	Abnormality of peripheral nerve conduction	8	6.625753e-3	1.000000e+0	1.000000e+0	1.509262e+2	6.625753e-3	1	6.625753e-3	1.000000e+0	10	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	LARS2
Human Phenotype	HP:0000138	Ovarian cysts	9	6.787544e-3	1.000000e+0	1.000000e+0	1.473287e+2	6.787544e-3	1	6.787544e-3	1.000000e+0	6	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	LARS2
Human Phenotype	HP:0000786	Primary amenorrhea	10	9.617744e-3	1.000000e+0	1.000000e+0	1.039745e+2	9.617744e-3	1	9.617744e-3	1.000000e+0	6	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	LARS2
Human Phenotype	HP:0000130	Abnormality of the uterus	11	9.892803e-3	1.000000e+0	1.000000e+0	1.010836e+2	9.892803e-3	1	9.892803e-3	1.000000e+0	11	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	LARS2
Human Phenotype	HP:0000141	Amenorrhea	12	1.078052e-2	1.000000e+0	1.000000e+0	9.275989e+1	1.078052e-2	1	1.078052e-2	1.000000e+0	12	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	LARS2
Human Phenotype	HP:0000137	Abnormality of the ovary	13	1.185914e-2	1.000000e+0	1.000000e+0	8.432312e+1	1.185914e-2	1	1.185914e-2	1.000000e+0	13	1.039385e-2	1.000000e+0	1.000000e+0	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	LARS2
Human Phenotype	HP:0000597	Ophthalmoparesis	14	1.196580e-2	1.000000e+0	1.000000e+0	8.357152e+1	1.196580e-2	1	1.196580e-2	1.000000e+0	17	1.667005e-2	1.000000e+0	1.000000e+0	5.973841e+1	1.673965e-2	1	151	5.000000e-1	6.622517e-3	unnamed	LARS2
Human Phenotype	HP:0000140	Abnormality of the menstrual cycle	15	1.313793e-2	1.000000e+0	1.000000e+0	7.611552e+1	1.313793e-2	1	1.313793e-2	1.000000e+0	14	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	LARS2
Human Phenotype	HP:0002120	Cerebral cortical atrophy	16	1.433858e-2	1.000000e+0	1.000000e+0	6.974193e+1	1.433858e-2	1	1.433858e-2	1.000000e+0	15	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	LARS2
Human Phenotype	HP:0004374	Hemiplegia/hemiparesis	17	1.698524e-2	1.000000e+0	1.000000e+0	5.887465e+1	1.698524e-2	1	1.698524e-2	1.000000e+0	16	1.568040e-2	1.000000e+0	1.000000e+0	6.352465e+1	1.574192e-2	1	142	5.000000e-1	7.042254e-3	unnamed	LARS2
Human Phenotype	HP:0007360	Aplasia/Hypoplasia of the cerebellum	18	1.999084e-2	1.000000e+0	1.000000e+0	5.002291e+1	1.999084e-2	1	1.999084e-2	1.000000e+0	18	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	LARS2
Human Phenotype	HP:0010549	Paralysis due to lesions of the principle motor tracts	19	2.184856e-2	1.000000e+0	1.000000e+0	4.576962e+1	2.184856e-2	1	2.184856e-2	1.000000e+0	19	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	LARS2
Human Phenotype	HP:0008373	Puberty and gonadal disorders	20	2.230960e-2	1.000000e+0	1.000000e+0	4.482376e+1	2.230960e-2	1	2.230960e-2	1.000000e+0	20	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	LARS2
Human Phenotype	HP:0002059	Cerebral atrophy	21	2.274528e-2	1.000000e+0	1.000000e+0	4.396517e+1	2.274528e-2	1	2.274528e-2	1.000000e+0	21	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	LARS2
Human Phenotype	HP:0007369	Atrophy/Degeneration affecting the cerebrum	22	2.306765e-2	1.000000e+0	1.000000e+0	4.335075e+1	2.306765e-2	1	2.306765e-2	1.000000e+0	22	2.259752e-2	1.000000e+0	1.000000e+0	4.400244e+1	2.272601e-2	1	205	5.000000e-1	4.878049e-3	unnamed	LARS2
Human Phenotype	HP:0012444	Brain atrophy	23	2.343110e-2	1.000000e+0	1.000000e+0	4.267832e+1	2.343110e-2	1	2.343110e-2	1.000000e+0	23	2.314545e-2	1.000000e+0	1.000000e+0	4.295476e+1	2.328031e-2	1	210	5.000000e-1	4.761905e-3	unnamed	LARS2
Human Phenotype	HP:0009830	Peripheral neuropathy	24	2.399642e-2	1.000000e+0	1.000000e+0	4.167288e+1	2.399642e-2	1	2.399642e-2	1.000000e+0	26	2.752338e-2	1.000000e+0	1.000000e+0	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	LARS2
Human Phenotype	HP:0002311	Incoordination	25	2.557425e-2	1.000000e+0	1.000000e+0	3.910184e+1	2.557425e-2	1	2.557425e-2	1.000000e+0	24	2.402182e-2	1.000000e+0	1.000000e+0	4.137844e+1	2.416717e-2	1	218	5.000000e-1	4.587156e-3	unnamed	LARS2
Human Phenotype	HP:0007367	Atrophy/Degeneration affecting the central nervous system	26	2.578991e-2	1.000000e+0	1.000000e+0	3.877485e+1	2.578991e-2	1	2.578991e-2	1.000000e+0	25	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	LARS2
Human Phenotype	HP:0000508	Ptosis	27	2.965278e-2	1.000000e+0	1.000000e+0	3.372365e+1	2.965278e-2	1	2.965278e-2	1.000000e+0	28	3.112777e-2	1.000000e+0	1.000000e+0	3.187456e+1	3.137298e-2	1	283	5.000000e-1	3.533569e-3	unnamed	LARS2
Human Phenotype	HP:0000008	Abnormality of female internal genitalia	28	3.365925e-2	1.000000e+0	1.000000e+0	2.970951e+1	3.365925e-2	1	3.365925e-2	1.000000e+0	27	2.981786e-2	1.000000e+0	1.000000e+0	3.328598e+1	3.004268e-2	1	271	5.000000e-1	3.690037e-3	unnamed	LARS2
Human Phenotype	HP:0010460	Abnormality of the female genitalia	29	3.799718e-2	1.000000e+0	1.000000e+0	2.631774e+1	3.799718e-2	1	3.799718e-2	1.000000e+0	29	3.418080e-2	1.000000e+0	1.000000e+0	2.900482e+1	3.447702e-2	1	311	5.000000e-1	3.215434e-3	unnamed	LARS2
Human Phenotype	HP:0011443	Abnormality of coordination	30	4.159660e-2	1.000000e+0	1.000000e+0	2.404043e+1	4.159660e-2	1	4.159660e-2	1.000000e+0	31	4.482844e-2	1.000000e+0	1.000000e+0	2.205501e+1	4.534117e-2	1	409	5.000000e-1	2.444988e-3	unnamed	LARS2
Human Phenotype	HP:0002650	Scoliosis	31	4.610557e-2	1.000000e+0	1.000000e+0	2.168935e+1	4.610557e-2	1	4.610557e-2	1.000000e+0	30	4.396146e-2	1.000000e+0	1.000000e+0	2.249501e+1	4.445430e-2	1	401	5.000000e-1	2.493766e-3	unnamed	LARS2
Human Phenotype	HP:0000407	Sensorineural hearing impairment	32	4.795301e-2	1.000000e+0	1.000000e+0	2.085375e+1	4.795301e-2	1	4.795301e-2	1.000000e+0	32	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	LARS2
Human Phenotype	HP:0001317	Abnormality of the cerebellum	33	4.894940e-2	1.000000e+0	1.000000e+0	2.042926e+1	4.894940e-2	1	4.894940e-2	1.000000e+0	38	5.423149e-2	1.000000e+0	1.000000e+0	1.818649e+1	5.498587e-2	1	496	5.000000e-1	2.016129e-3	unnamed	LARS2
Human Phenotype	HP:0000759	Abnormality of the peripheral nervous system	34	4.946470e-2	1.000000e+0	1.000000e+0	2.021644e+1	4.946470e-2	1	4.946470e-2	1.000000e+0	36	5.196604e-2	1.000000e+0	1.000000e+0	1.899053e+1	5.265783e-2	1	475	5.000000e-1	2.105263e-3	unnamed	LARS2
Human Phenotype	HP:0011389	Functional abnormality of the inner ear	35	5.010074e-2	1.000000e+0	1.000000e+0	1.995978e+1	5.010074e-2	1	5.010074e-2	1.000000e+0	34	4.937365e-2	1.000000e+0	1.000000e+0	2.000111e+1	4.999723e-2	1	451	5.000000e-1	2.217295e-3	unnamed	LARS2
Human Phenotype	HP:0010674	Abnormality of the curvature of the vertebral column	36	5.014164e-2	1.000000e+0	1.000000e+0	1.994351e+1	5.014164e-2	1	5.014164e-2	1.000000e+0	33	4.926556e-2	1.000000e+0	1.000000e+0	2.004556e+1	4.988637e-2	1	450	5.000000e-1	2.222222e-3	unnamed	LARS2
Human Phenotype	HP:0000359	Abnormality of the inner ear	37	5.043815e-2	1.000000e+0	1.000000e+0	1.982626e+1	5.043815e-2	1	5.043815e-2	1.000000e+0	35	4.980596e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	455	5.000000e-1	2.197802e-3	unnamed	LARS2
Human Phenotype	HP:0000639	Nystagmus	38	5.150322e-2	1.000000e+0	1.000000e+0	1.941626e+1	5.150322e-2	1	5.150322e-2	1.000000e+0	37	5.293728e-2	1.000000e+0	1.000000e+0	1.863740e+1	5.365556e-2	1	484	5.000000e-1	2.066116e-3	unnamed	LARS2
Human Phenotype	HP:0000496	Abnormality of eye movement	39	5.789715e-2	1.000000e+0	1.000000e+0	1.727201e+1	5.789715e-2	1	5.789715e-2	1.000000e+0	40	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	LARS2
Human Phenotype	HP:0000818	Abnormality of the endocrine system	40	5.830630e-2	1.000000e+0	1.000000e+0	1.715081e+1	5.830630e-2	1	5.830630e-2	1.000000e+0	42	6.294423e-2	1.000000e+0	1.000000e+0	1.563345e+1	6.396541e-2	1	577	5.000000e-1	1.733102e-3	unnamed	LARS2
Human Phenotype	HP:0007256	Abnormality of pyramidal motor function	41	5.852599e-2	1.000000e+0	1.000000e+0	1.708643e+1	5.852599e-2	1	5.852599e-2	1.000000e+0	43	6.466050e-2	1.000000e+0	1.000000e+0	1.521164e+1	6.573915e-2	1	593	5.000000e-1	1.686341e-3	unnamed	LARS2
Human Phenotype	HP:0002062	Abnormality of the pyramidal tracts	42	5.873395e-2	1.000000e+0	1.000000e+0	1.702593e+1	5.873395e-2	1	5.873395e-2	1.000000e+0	44	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	LARS2
Human Phenotype	HP:0004322	Short stature	43	6.307451e-2	1.000000e+0	1.000000e+0	1.585427e+1	6.307451e-2	1	6.307451e-2	1.000000e+0	41	6.197814e-2	1.000000e+0	1.000000e+0	1.588116e+1	6.296768e-2	1	568	5.000000e-1	1.760563e-3	unnamed	LARS2
Human Phenotype	HP:0000812	Abnormal internal genitalia	44	6.482038e-2	1.000000e+0	1.000000e+0	1.542725e+1	6.482038e-2	1	6.482038e-2	1.000000e+0	39	6.068925e-2	1.000000e+0	1.000000e+0	1.622392e+1	6.163738e-2	1	556	5.000000e-1	1.798561e-3	unnamed	LARS2
Human Phenotype	HP:0002977	Aplasia/Hypoplasia involving the central nervous system	45	6.843249e-2	1.000000e+0	1.000000e+0	1.461294e+1	6.843249e-2	1	6.843249e-2	1.000000e+0	48	7.150984e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	657	5.000000e-1	1.522070e-3	unnamed	LARS2
Human Phenotype	HP:0000002	Abnormality of body height	46	6.858327e-2	1.000000e+0	1.000000e+0	1.458081e+1	6.858327e-2	1	6.858327e-2	1.000000e+0	46	6.637520e-2	1.000000e+0	1.000000e+0	1.481199e+1	6.751289e-2	1	609	5.000000e-1	1.642036e-3	unnamed	LARS2
Human Phenotype	HP:0000925	Abnormality of the vertebral column	47	6.929502e-2	1.000000e+0	1.000000e+0	1.443105e+1	6.929502e-2	1	6.929502e-2	1.000000e+0	45	6.551805e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	LARS2
Human Phenotype	HP:0012243	Abnormal genital system morphology	48	7.339808e-2	1.000000e+0	1.000000e+0	1.362434e+1	7.339808e-2	1	7.339808e-2	1.000000e+0	47	6.712488e-2	1.000000e+0	1.000000e+0	1.464367e+1	6.828890e-2	1	616	5.000000e-1	1.623377e-3	unnamed	LARS2
Human Phenotype	HP:0000365	Hearing impairment	49	7.358601e-2	1.000000e+0	1.000000e+0	1.358954e+1	7.358601e-2	1	7.358601e-2	1.000000e+0	49	7.300478e-2	1.000000e+0	1.000000e+0	1.344337e+1	7.438612e-2	1	671	5.000000e-1	1.490313e-3	unnamed	LARS2
Human Phenotype	HP:0000364	Hearing abnormality	50	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	50	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	LARS2
Human Phenotype	HP:0002060	Abnormality of the cerebrum	51	7.579775e-2	1.000000e+0	1.000000e+0	1.319300e+1	7.579775e-2	1	7.579775e-2	1.000000e+0	52	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	LARS2
Human Phenotype	HP:0100547	Abnormality of the forebrain	52	7.625082e-2	1.000000e+0	1.000000e+0	1.311461e+1	7.625082e-2	1	7.625082e-2	1.000000e+0	54	7.918527e-2	1.000000e+0	1.000000e+0	1.237380e+1	8.081592e-2	1	729	5.000000e-1	1.371742e-3	unnamed	LARS2
Human Phenotype	HP:0001510	Growth delay	53	7.829812e-2	1.000000e+0	1.000000e+0	1.277170e+1	7.829812e-2	1	7.829812e-2	1.000000e+0	52	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	LARS2
Human Phenotype	HP:0000078	Abnormality of the genital system	54	7.832480e-2	1.000000e+0	1.000000e+0	1.276735e+1	7.832480e-2	1	7.832480e-2	1.000000e+0	51	7.513832e-2	1.000000e+0	1.000000e+0	1.305427e+1	7.660329e-2	1	691	5.000000e-1	1.447178e-3	unnamed	LARS2
Human Phenotype	HP:0011442	Abnormality of central motor function	55	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	55	8.767615e-2	1.000000e+0	1.000000e+0	1.115019e+1	8.968461e-2	1	809	5.000000e-1	1.236094e-3	unnamed	LARS2
Human Phenotype	HP:0012443	Abnormality of the brain	56	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	56	9.833972e-2	1.000000e+0	1.000000e+0	9.912637e+0	1.008813e-1	1	910	5.000000e-1	1.098901e-3	unnamed	LARS2
Human Phenotype	HP:0000598	Abnormality of the ear	57	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	57	1.062177e-1	1.000000e+0	1.000000e+0	9.157868e+0	1.091957e-1	1	985	5.000000e-1	1.015228e-3	unnamed	LARS2
Human Phenotype	HP:0012373	Abnormal eye physiology	58	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	58	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	LARS2
Human Phenotype	HP:0001507	Growth abnormality	59	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	59	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	LARS2
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	60	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	60	1.209346e-1	1.000000e+0	1.000000e+0	8.011101e+0	1.248268e-1	1	1126	5.000000e-1	8.880995e-4	unnamed	LARS2
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	61	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	62	1.321245e-1	1.000000e+0	1.000000e+0	7.309968e+0	1.367995e-1	1	1234	5.000000e-1	8.103728e-4	unnamed	LARS2
Human Phenotype	HP:0009121	Abnormal axial skeleton morphology	62	1.232157e-1	1.000000e+0	1.000000e+0	8.115849e+0	1.232157e-1	1	1.232157e-1	1.000000e+0	61	1.216620e-1	1.000000e+0	1.000000e+0	7.961606e+0	1.256028e-1	1	1133	5.000000e-1	8.826125e-4	unnamed	LARS2
Human Phenotype	HP:0100543	Cognitive impairment	63	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	63	1.328473e-1	1.000000e+0	1.000000e+0	7.268735e+0	1.375755e-1	1	1241	5.000000e-1	8.058018e-4	unnamed	LARS2
Human Phenotype	HP:0000007	Autosomal recessive inheritance	64	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	68	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	LARS2
Human Phenotype	HP:0000478	Abnormality of the eye	65	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	64	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	LARS2
Human Phenotype	HP:0011446	Abnormality of higher mental function	66	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	65	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	LARS2
Human Phenotype	HP:0011842	Abnormality of skeletal morphology	67	1.489554e-1	1.000000e+0	1.000000e+0	6.713421e+0	1.489554e-1	1	1.489554e-1	1.000000e+0	66	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	LARS2
Human Phenotype	HP:0000924	Abnormality of the skeletal system	68	1.521487e-1	1.000000e+0	1.000000e+0	6.572520e+0	1.521487e-1	1	1.521487e-1	1.000000e+0	67	1.555123e-1	1.000000e+0	1.000000e+0	6.169973e+0	1.620753e-1	1	1462	5.000000e-1	6.839945e-4	unnamed	LARS2
Human Phenotype	HP:0002011	Abnormality of the central nervous system	69	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	69	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	LARS2
Human Phenotype	HP:0000707	Abnormality of the nervous system	70	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	70	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	LARS2
Human Phenotype	HP:0000005	Mode of inheritance	71	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	71	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	LARS2
Human Phenotype	HP:0000118	Phenotypic abnormality	72	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	72	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	LARS2
Human Phenotype	HP:0000001	All	73	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	73	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	LARS2
Disease Ontology	DOID:9261	nasopharynx carcinoma	1	2.238691e-2	1.000000e+0	1.000000e+0	4.466897e+1	2.238691e-2	1	2.238691e-2	1.000000e+0	3	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	LARS2
Disease Ontology	DOID:3312	bipolar disease	2	2.564536e-2	1.000000e+0	1.000000e+0	3.899341e+1	2.564536e-2	1	2.564536e-2	1.000000e+0	1	1.667005e-2	1.000000e+0	1.000000e+0	5.973841e+1	1.673965e-2	1	151	5.000000e-1	6.622517e-3	unnamed	LARS2
Disease Ontology	DOID:3324	mood disease	3	2.706324e-2	1.000000e+0	1.000000e+0	3.695049e+1	2.706324e-2	1	2.706324e-2	1.000000e+0	2	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	LARS2
Disease Ontology	DOID:5419	schizophrenia	4	8.467094e-2	1.000000e+0	1.000000e+0	1.181043e+1	8.467094e-2	1	8.467094e-2	1.000000e+0	4	6.947907e-2	1.000000e+0	1.000000e+0	1.413871e+1	7.072779e-2	1	638	5.000000e-1	1.567398e-3	unnamed	LARS2
Disease Ontology	DOID:2468	psychotic disease	5	8.473193e-2	1.000000e+0	1.000000e+0	1.180193e+1	8.473193e-2	1	8.473193e-2	1.000000e+0	5	6.969294e-2	1.000000e+0	1.000000e+0	1.409453e+1	7.094950e-2	1	640	5.000000e-1	1.562500e-3	unnamed	LARS2
Disease Ontology	DOID:9351	diabetes mellitus	6	9.310870e-2	1.000000e+0	1.000000e+0	1.074013e+1	9.310870e-2	1	9.310870e-2	1.000000e+0	8	9.465152e-2	1.000000e+0	1.000000e+0	1.030914e+1	9.700127e-2	1	875	5.000000e-1	1.142857e-3	unnamed	LARS2
Disease Ontology	DOID:1428	endocrine pancreas disease	7	9.553022e-2	1.000000e+0	1.000000e+0	1.046789e+1	9.553022e-2	1	9.553022e-2	1.000000e+0	9	9.654925e-2	1.000000e+0	1.000000e+0	1.010134e+1	9.899673e-2	1	893	5.000000e-1	1.119821e-3	unnamed	LARS2
Disease Ontology	DOID:4194	glucose metabolism disease	8	9.709597e-2	1.000000e+0	1.000000e+0	1.029909e+1	9.709597e-2	1	9.709597e-2	1.000000e+0	10	9.844499e-2	1.000000e+0	1.000000e+0	9.901756e+0	1.009922e-1	1	911	5.000000e-1	1.097695e-3	unnamed	LARS2
Disease Ontology	DOID:26	pancreas disease	9	9.807021e-2	1.000000e+0	1.000000e+0	1.019678e+1	9.807021e-2	1	9.807021e-2	1.000000e+0	11	1.001284e-1	1.000000e+0	1.000000e+0	9.730852e+0	1.027659e-1	1	927	5.000000e-1	1.078749e-3	unnamed	LARS2
Disease Ontology	DOID:0050013	carbohydrate metabolism disease	10	1.011074e-1	1.000000e+0	1.000000e+0	9.890476e+0	1.011074e-1	1	1.011074e-1	1.000000e+0	12	1.026506e-1	1.000000e+0	1.000000e+0	9.485279e+0	1.054265e-1	1	951	5.000000e-1	1.051525e-3	unnamed	LARS2
Disease Ontology	DOID:0060035	medical disorder	11	1.146356e-1	1.000000e+0	1.000000e+0	8.723297e+0	1.146356e-1	1	1.146356e-1	1.000000e+0	7	9.148422e-2	1.000000e+0	1.000000e+0	1.067515e+1	9.367552e-2	1	845	5.000000e-1	1.183432e-3	unnamed	LARS2
Disease Ontology	DOID:1561	cognitive disease	12	1.201035e-1	1.000000e+0	1.000000e+0	8.326155e+0	1.201035e-1	1	1.201035e-1	1.000000e+0	13	1.103005e-1	1.000000e+0	1.000000e+0	8.809082e+0	1.135192e-1	1	1024	5.000000e-1	9.765625e-4	unnamed	LARS2
Disease Ontology	DOID:28	endocrine system disease	13	1.359578e-1	1.000000e+0	1.000000e+0	7.355222e+0	1.359578e-1	1	1.359578e-1	1.000000e+0	14	1.392361e-1	1.000000e+0	1.000000e+0	6.922870e+0	1.444488e-1	1	1303	5.000000e-1	7.674597e-4	unnamed	LARS2
Disease Ontology	DOID:0014667	disease of metabolism	14	1.387898e-1	1.000000e+0	1.000000e+0	7.205143e+0	1.387898e-1	1	1.387898e-1	1.000000e+0	15	1.487750e-1	1.000000e+0	1.000000e+0	6.461676e+0	1.547586e-1	1	1396	5.000000e-1	7.163324e-4	unnamed	LARS2
Disease Ontology	DOID:77	gastrointestinal system disease	15	1.566959e-1	1.000000e+0	1.000000e+0	6.381787e+0	1.566959e-1	1	1.566959e-1	1.000000e+0	21	1.749595e-1	1.000000e+0	1.000000e+0	5.453748e+0	1.833601e-1	1	1654	5.000000e-1	6.045949e-4	unnamed	LARS2
Disease Ontology	DOID:4241	malignant neoplasm of breast	16	1.689834e-1	1.000000e+0	1.000000e+0	5.917740e+0	1.689834e-1	1	1.689834e-1	1.000000e+0	17	1.624258e-1	1.000000e+0	1.000000e+0	5.895752e+0	1.696137e-1	1	1530	5.000000e-1	6.535948e-4	unnamed	TMEM158
Disease Ontology	DOID:3937	malignant neoplasm of thorax	17	1.691008e-1	1.000000e+0	1.000000e+0	5.913634e+0	1.691008e-1	1	1.691008e-1	1.000000e+0	18	1.626287e-1	1.000000e+0	1.000000e+0	5.888055e+0	1.698354e-1	1	1532	5.000000e-1	6.527415e-4	unnamed	TMEM158
Disease Ontology	DOID:5093	thoracic cancer	18	1.702657e-1	1.000000e+0	1.000000e+0	5.873173e+0	1.702657e-1	1	1.702657e-1	1.000000e+0	19	1.639470e-1	1.000000e+0	1.000000e+0	5.838511e+0	1.712765e-1	1	1545	5.000000e-1	6.472492e-4	unnamed	TMEM158
Disease Ontology	DOID:150	disease of mental health	19	1.737444e-1	1.000000e+0	1.000000e+0	5.755580e+0	1.737444e-1	1	1.737444e-1	1.000000e+0	16	1.522491e-1	1.000000e+0	1.000000e+0	6.308042e+0	1.585278e-1	1	1430	5.000000e-1	6.993007e-4	unnamed	LARS2
Disease Ontology	DOID:1612	mammary cancer	20	1.772500e-1	1.000000e+0	1.000000e+0	5.641748e+0	1.772500e-1	1	1.772500e-1	1.000000e+0	20	1.677945e-1	1.000000e+0	1.000000e+0	5.698358e+0	1.754892e-1	1	1583	5.000000e-1	6.317119e-4	unnamed	TMEM158
Disease Ontology	DOID:193	reproductive system cancer	21	2.095200e-1	1.000000e+0	1.000000e+0	4.772814e+0	2.095200e-1	1	2.095200e-1	1.000000e+0	23	2.033098e-1	1.000000e+0	1.000000e+0	4.654541e+0	2.148440e-1	1	1938	5.000000e-1	5.159959e-4	unnamed	TMEM158
Disease Ontology	DOID:305	carcinoma	22	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	24	3.253901e-1	1.000000e+0	1.000000e+0	2.798790e+0	3.572973e-1	1	3223	5.000000e-1	3.102699e-4	unnamed	LARS2
Disease Ontology	DOID:462	cancer by anatomical entity	23	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	25	3.467081e-1	1.000000e+0	1.000000e+0	2.607835e+0	3.834599e-1	1	3459	5.000000e-1	2.891009e-4	unnamed	TMEM158
Disease Ontology	DOID:162	cancer	24	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	6	7.990207e-2	1.000000e+0	1.000000e+0	3.537451e+0	5.653789e-1	2	5100	1.000000e+0	3.921569e-4	unnamed	LARS2,TMEM158
Disease Ontology	DOID:7	disease of anatomical entity	25	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	26	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	LARS2
Disease Ontology	DOID:4	disease	26	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	22	1.910563e-1	1.000000e+0	1.000000e+0	2.287725e+0	8.742309e-1	2	7886	1.000000e+0	2.536140e-4	unnamed	LARS2,TMEM158
MSigDB Cancer Neighborhood	MORF_EIF4E	Neighborhood of EIF4E	1	5.941204e-3	1.000000e+0	1.000000e+0	1.683161e+2	5.941204e-3	1	5.941204e-3	1.000000e+0	2	9.290700e-3	1.000000e+0	1.000000e+0	1.073869e+2	9.312122e-3	1	84	5.000000e-1	1.190476e-2	unnamed	LARS2
MSigDB Cancer Neighborhood	MORF_CCNF	Neighborhood of CCNF	2	6.811518e-3	1.000000e+0	1.000000e+0	1.468102e+2	6.811518e-3	1	6.811518e-3	1.000000e+0	1	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	LARS2
BioCyc Pathway	TRNA-CHARGING-PWY	tRNA charging	1	2.731071e-3	9.067156e-1	9.067156e-1	3.661567e+2	2.731071e-3	1	2.731071e-3	1.000000e+0	1	4.097676e-3	1.000000e+0	1.000000e+0	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	LARS2
MSigDB Pathway	KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS	Valine, leucine and isoleucine biosynthesis	1	1.414020e-3	1.000000e+0	1.000000e+0	7.072034e+2	1.414020e-3	1	1.414020e-3	1.000000e+0	1	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	LARS2
MSigDB Pathway	REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION	Genes involved in Mitochondrial tRNA aminoacylation	2	1.582801e-3	1.000000e+0	1.000000e+0	6.317915e+2	1.582801e-3	1	1.582801e-3	1.000000e+0	2	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	LARS2
MSigDB Pathway	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS	Aminoacyl-tRNA biosynthesis	3	2.786516e-3	1.000000e+0	1.000000e+0	3.588711e+2	2.786516e-3	1	2.786516e-3	1.000000e+0	3	4.540164e-3	1.000000e+0	1.000000e+0	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	LARS2
MSigDB Pathway	REACTOME_TRNA_AMINOACYLATION	Genes involved in tRNA Aminoacylation	4	3.100863e-3	1.000000e+0	1.000000e+0	3.224909e+2	3.100863e-3	1	3.100863e-3	1.000000e+0	4	4.650770e-3	1.000000e+0	1.000000e+0	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	LARS2
MGI Expression: Detected	15572	TS15_embryo endoderm	1	3.263913e-3	1.000000e+0	1.000000e+0	3.063807e+2	3.263913e-3	1	3.263913e-3	1.000000e+0	1	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	TMEM158
MGI Expression: Detected	7039	TS28_lymph node	2	2.860887e-2	1.000000e+0	1.000000e+0	3.495420e+1	2.860887e-2	1	2.860887e-2	1.000000e+0	2	2.577339e-2	1.000000e+0	1.000000e+0	3.854915e+1	2.594091e-2	1	234	5.000000e-1	4.273504e-3	unnamed	TMEM158
MGI Expression: Detected	16160	TS22_pancreas epithelium	3	3.483643e-2	1.000000e+0	1.000000e+0	2.870558e+1	3.483643e-2	1	3.483643e-2	1.000000e+0	5	4.114105e-2	1.000000e+0	1.000000e+0	2.405467e+1	4.157197e-2	1	375	5.000000e-1	2.666667e-3	unnamed	LARS2
MGI Expression: Detected	3724	TS19_neural tube	4	5.697721e-2	1.000000e+0	1.000000e+0	1.755088e+1	5.697721e-2	1	5.697721e-2	1.000000e+0	3	3.483439e-2	1.000000e+0	1.000000e+0	2.845584e+1	3.514218e-2	1	317	5.000000e-1	3.154574e-3	unnamed	TMEM158
MGI Expression: Detected	2415	TS17_neural tube	5	6.669026e-2	1.000000e+0	1.000000e+0	1.499469e+1	6.669026e-2	1	6.669026e-2	1.000000e+0	4	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	TMEM158
MGI Expression: Detected	6982	TS28_large intestine	6	9.579875e-2	1.000000e+0	1.000000e+0	1.043855e+1	9.579875e-2	1	9.579875e-2	1.000000e+0	9	9.422953e-2	1.000000e+0	1.000000e+0	1.035649e+1	9.655784e-2	1	871	5.000000e-1	1.148106e-3	unnamed	TMEM158
MGI Expression: Detected	2414	TS17_future spinal cord	7	9.813548e-2	1.000000e+0	1.000000e+0	1.018999e+1	9.813548e-2	1	9.813548e-2	1.000000e+0	6	6.755314e-2	1.000000e+0	1.000000e+0	1.454919e+1	6.873233e-2	1	620	5.000000e-1	1.612903e-3	unnamed	TMEM158
MGI Expression: Detected	6978	TS28_small intestine	8	1.052270e-1	1.000000e+0	1.000000e+0	9.503261e+0	1.052270e-1	1	1.052270e-1	1.000000e+0	12	1.029656e-1	1.000000e+0	1.000000e+0	9.455451e+0	1.057591e-1	1	954	5.000000e-1	1.048218e-3	unnamed	TMEM158
MGI Expression: Detected	3882	TS19_limb	9	1.220645e-1	1.000000e+0	1.000000e+0	8.192389e+0	1.220645e-1	1	1.220645e-1	1.000000e+0	10	9.707604e-2	1.000000e+0	1.000000e+0	1.004510e+1	9.955102e-2	1	898	5.000000e-1	1.113586e-3	unnamed	TMEM158
MGI Expression: Detected	2590	TS17_limb	10	1.222354e-1	1.000000e+0	1.000000e+0	8.180938e+0	1.222354e-1	1	1.222354e-1	1.000000e+0	11	1.001284e-1	1.000000e+0	1.000000e+0	9.730852e+0	1.027659e-1	1	927	5.000000e-1	1.078749e-3	unnamed	TMEM158
MGI Expression: Detected	6977	TS28_intestine	11	1.420131e-1	1.000000e+0	1.000000e+0	7.041603e+0	1.420131e-1	1	1.420131e-1	1.000000e+0	13	1.416001e-1	1.000000e+0	1.000000e+0	6.802790e+0	1.469985e-1	1	1326	5.000000e-1	7.541478e-4	unnamed	TMEM158
MGI Expression: Detected	7037	TS28_thymus	12	1.474841e-1	1.000000e+0	1.000000e+0	6.780393e+0	1.474841e-1	1	1.474841e-1	1.000000e+0	15	1.575486e-1	1.000000e+0	1.000000e+0	6.086707e+0	1.642924e-1	1	1482	5.000000e-1	6.747638e-4	unnamed	TMEM158
MGI Expression: Detected	6048	TS22_pancreas	13	1.480883e-1	1.000000e+0	1.000000e+0	6.752730e+0	1.480883e-1	1	1.480883e-1	1.000000e+0	14	1.441660e-1	1.000000e+0	1.000000e+0	6.676906e+0	1.497700e-1	1	1351	5.000000e-1	7.401925e-4	unnamed	LARS2
MGI Expression: Detected	7038	TS28_spleen	14	1.850698e-1	1.000000e+0	1.000000e+0	5.403366e+0	1.850698e-1	1	1.850698e-1	1.000000e+0	18	1.970636e-1	1.000000e+0	1.000000e+0	4.810933e+0	2.078599e-1	1	1875	5.000000e-1	5.333333e-4	unnamed	TMEM158
MGI Expression: Detected	6965	TS28_gastrointestinal system	15	1.989085e-1	1.000000e+0	1.000000e+0	5.027437e+0	1.989085e-1	1	1.989085e-1	1.000000e+0	19	1.984538e-1	1.000000e+0	1.000000e+0	4.775278e+0	2.094119e-1	1	1889	5.000000e-1	5.293806e-4	unnamed	TMEM158
MGI Expression: Detected	3723	TS19_future spinal cord	16	2.082973e-1	1.000000e+0	1.000000e+0	4.800830e+0	2.082973e-1	1	2.082973e-1	1.000000e+0	16	1.703209e-1	1.000000e+0	1.000000e+0	5.609764e+0	1.782606e-1	1	1608	5.000000e-1	6.218905e-4	unnamed	TMEM158
MGI Expression: Detected	6963	TS28_liver	17	2.213497e-1	1.000000e+0	1.000000e+0	4.517739e+0	2.213497e-1	1	2.213497e-1	1.000000e+0	28	2.458689e-1	1.000000e+0	1.000000e+0	3.799705e+0	2.631783e-1	1	2374	5.000000e-1	4.212300e-4	unnamed	TMEM158
MGI Expression: Detected	2413	TS17_central nervous system	18	2.230048e-1	1.000000e+0	1.000000e+0	4.484208e+0	2.230048e-1	1	2.230048e-1	1.000000e+0	20	1.997435e-1	1.000000e+0	1.000000e+0	4.742639e+0	2.108531e-1	1	1902	5.000000e-1	5.257624e-4	unnamed	TMEM158
MGI Expression: Detected	7036	TS28_haemolymphoid system	19	2.241684e-1	1.000000e+0	1.000000e+0	4.460933e+0	2.241684e-1	1	2.241684e-1	1.000000e+0	26	2.393082e-1	1.000000e+0	1.000000e+0	3.911752e+0	2.556399e-1	1	2306	5.000000e-1	4.336513e-4	unnamed	TMEM158
MGI Expression: Detected	2412	TS17_nervous system	20	2.273547e-1	1.000000e+0	1.000000e+0	4.398414e+0	2.273547e-1	1	2.273547e-1	1.000000e+0	21	2.029139e-1	1.000000e+0	1.000000e+0	4.664168e+0	2.144005e-1	1	1934	5.000000e-1	5.170631e-4	unnamed	TMEM158
MGI Expression: Detected	6962	TS28_liver and biliary system	21	2.293478e-1	1.000000e+0	1.000000e+0	4.360190e+0	2.293478e-1	1	2.293478e-1	1.000000e+0	31	2.531680e-1	1.000000e+0	1.000000e+0	3.681837e+0	2.716036e-1	1	2450	5.000000e-1	4.081633e-4	unnamed	TMEM158
MGI Expression: Detected	6952	TS28_testis	22	2.313330e-1	1.000000e+0	1.000000e+0	4.322774e+0	2.313330e-1	1	2.313330e-1	1.000000e+0	27	2.397915e-1	1.000000e+0	1.000000e+0	3.903289e+0	2.561942e-1	1	2311	5.000000e-1	4.327131e-4	unnamed	TMEM158
MGI Expression: Detected	6951	TS28_male reproductive system	23	2.379727e-1	1.000000e+0	1.000000e+0	4.202163e+0	2.379727e-1	1	2.379727e-1	1.000000e+0	29	2.476009e-1	1.000000e+0	1.000000e+0	3.771112e+0	2.651738e-1	1	2392	5.000000e-1	4.180602e-4	unnamed	TMEM158
MGI Expression: Detected	3745	TS19_brain	24	2.420821e-1	1.000000e+0	1.000000e+0	4.130830e+0	2.420821e-1	1	2.420821e-1	1.000000e+0	17	1.909925e-1	1.000000e+0	1.000000e+0	4.972712e+0	2.010975e-1	1	1814	5.000000e-1	5.512679e-4	unnamed	TMEM158
MGI Expression: Detected	6960	TS28_kidney	25	2.525264e-1	1.000000e+0	1.000000e+0	3.959982e+0	2.525264e-1	1	2.525264e-1	1.000000e+0	32	2.607175e-1	1.000000e+0	1.000000e+0	3.566825e+0	2.803614e-1	1	2529	5.000000e-1	3.954132e-4	unnamed	TMEM158
MGI Expression: Detected	1016	TS15_embryo	26	2.533670e-1	1.000000e+0	1.000000e+0	3.946844e+0	2.533670e-1	1	2.533670e-1	1.000000e+0	24	2.237590e-1	1.000000e+0	1.000000e+0	4.203402e+0	2.379026e-1	1	2146	5.000000e-1	4.659832e-4	unnamed	TMEM158
MGI Expression: Detected	1015	Theiler_stage_15	27	2.573675e-1	1.000000e+0	1.000000e+0	3.885495e+0	2.573675e-1	1	2.573675e-1	1.000000e+0	25	2.277584e-1	1.000000e+0	1.000000e+0	4.124600e+0	2.424478e-1	1	2187	5.000000e-1	4.572474e-4	unnamed	TMEM158
MGI Expression: Detected	3722	TS19_central nervous system	28	2.576485e-1	1.000000e+0	1.000000e+0	3.881257e+0	2.576485e-1	1	2.576485e-1	1.000000e+0	22	2.037056e-1	1.000000e+0	1.000000e+0	4.644954e+0	2.152874e-1	1	1942	5.000000e-1	5.149331e-4	unnamed	TMEM158
MGI Expression: Detected	6959	TS28_renal-urinary system	29	2.619747e-1	1.000000e+0	1.000000e+0	3.817163e+0	2.619747e-1	1	2.619747e-1	1.000000e+0	34	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	TMEM158
MGI Expression: Detected	3721	TS19_nervous system	30	2.633549e-1	1.000000e+0	1.000000e+0	3.797158e+0	2.633549e-1	1	2.633549e-1	1.000000e+0	23	2.080524e-1	1.000000e+0	1.000000e+0	4.542044e+0	2.201652e-1	1	1986	5.000000e-1	5.035247e-4	unnamed	TMEM158
MGI Expression: Detected	6020	TS22_gut	31	2.671263e-1	1.000000e+0	1.000000e+0	3.743547e+0	2.671263e-1	1	2.671263e-1	1.000000e+0	30	2.480816e-1	1.000000e+0	1.000000e+0	3.763246e+0	2.657281e-1	1	2397	5.000000e-1	4.171882e-4	unnamed	LARS2
MGI Expression: Detected	6019	TS22_alimentary system	32	2.958102e-1	1.000000e+0	1.000000e+0	3.380547e+0	2.958102e-1	1	2.958102e-1	1.000000e+0	36	2.795646e-1	1.000000e+0	1.000000e+0	3.306635e+0	3.024223e-1	1	2728	5.000000e-1	3.665689e-4	unnamed	LARS2
MGI Expression: Detected	2165	TS17_organ system	33	3.004442e-1	1.000000e+0	1.000000e+0	3.328405e+0	3.004442e-1	1	3.004442e-1	1.000000e+0	33	2.687975e-1	1.000000e+0	1.000000e+0	3.450842e+0	2.897844e-1	1	2614	5.000000e-1	3.825555e-4	unnamed	TMEM158
MGI Expression: Detected	3399	TS19_organ system	34	3.233706e-1	1.000000e+0	1.000000e+0	3.092427e+0	3.233706e-1	1	3.233706e-1	1.000000e+0	35	2.724900e-1	1.000000e+0	1.000000e+0	3.400113e+0	2.941079e-1	1	2653	5.000000e-1	3.769318e-4	unnamed	TMEM158
MGI Expression: Detected	4000	TS20_embryo	35	3.348154e-1	1.000000e+0	1.000000e+0	2.986720e+0	3.348154e-1	1	3.348154e-1	1.000000e+0	37	2.872599e-1	1.000000e+0	1.000000e+0	3.210142e+0	3.115127e-1	1	2810	5.000000e-1	3.558719e-4	unnamed	TMEM158
MGI Expression: Detected	6950	TS28_reproductive system	36	3.370939e-1	1.000000e+0	1.000000e+0	2.966533e+0	3.370939e-1	1	3.370939e-1	1.000000e+0	46	3.615866e-1	1.000000e+0	1.000000e+0	2.487728e+0	4.019733e-1	1	3626	5.000000e-1	2.757860e-4	unnamed	TMEM158
MGI Expression: Detected	3999	Theiler_stage_20	37	3.376967e-1	1.000000e+0	1.000000e+0	2.961237e+0	3.376967e-1	1	3.376967e-1	1.000000e+0	38	2.900650e-1	1.000000e+0	1.000000e+0	3.176232e+0	3.148384e-1	1	2840	5.000000e-1	3.521127e-4	unnamed	TMEM158
MGI Expression: Detected	6018	TS22_visceral organ	38	3.446359e-1	1.000000e+0	1.000000e+0	2.901613e+0	3.446359e-1	1	3.446359e-1	1.000000e+0	45	3.321114e-1	1.000000e+0	1.000000e+0	2.735972e+0	3.655008e-1	1	3297	5.000000e-1	3.033060e-4	unnamed	LARS2
MGI Expression: Detected	2023	TS17_embryo	39	3.504112e-1	1.000000e+0	1.000000e+0	2.853790e+0	3.504112e-1	1	3.504112e-1	1.000000e+0	43	3.281190e-1	1.000000e+0	1.000000e+0	2.772979e+0	3.606230e-1	1	3253	5.000000e-1	3.074085e-4	unnamed	TMEM158
MGI Expression: Detected	2022	Theiler_stage_17	40	3.517739e-1	1.000000e+0	1.000000e+0	2.842735e+0	3.517739e-1	1	3.517739e-1	1.000000e+0	44	3.303888e-1	1.000000e+0	1.000000e+0	2.751830e+0	3.633945e-1	1	3278	5.000000e-1	3.050641e-4	unnamed	TMEM158
MGI Expression: Detected	4761	TS21_embryo	41	3.653552e-1	1.000000e+0	1.000000e+0	2.737062e+0	3.653552e-1	1	3.653552e-1	1.000000e+0	39	3.195499e-1	1.000000e+0	1.000000e+0	2.855492e+0	3.502023e-1	1	3159	5.000000e-1	3.165559e-4	unnamed	TMEM158
MGI Expression: Detected	4760	Theiler_stage_21	42	3.661005e-1	1.000000e+0	1.000000e+0	2.731490e+0	3.661005e-1	1	3.661005e-1	1.000000e+0	40	3.205555e-1	1.000000e+0	1.000000e+0	2.845584e+0	3.514218e-1	1	3170	5.000000e-1	3.154574e-4	unnamed	TMEM158
MGI Expression: Detected	3341	TS19_embryo	43	3.699199e-1	1.000000e+0	1.000000e+0	2.703288e+0	3.699199e-1	1	3.699199e-1	1.000000e+0	41	3.257542e-1	1.000000e+0	1.000000e+0	2.795321e+0	3.577407e-1	1	3227	5.000000e-1	3.098853e-4	unnamed	TMEM158
MGI Expression: Detected	3340	Theiler_stage_19	44	3.711587e-1	1.000000e+0	1.000000e+0	2.694265e+0	3.711587e-1	1	3.711587e-1	1.000000e+0	42	3.271190e-1	1.000000e+0	1.000000e+0	2.782387e+0	3.594036e-1	1	3242	5.000000e-1	3.084516e-4	unnamed	TMEM158
MGI Expression: Detected	6945	TS28_visceral organ	45	4.216843e-1	1.000000e+0	1.000000e+0	2.371443e+0	4.216843e-1	1	4.216843e-1	1.000000e+0	48	4.474230e-1	1.000000e+0	1.000000e+0	1.948272e+0	5.132753e-1	1	4630	5.000000e-1	2.159827e-4	unnamed	TMEM158
MGI Expression: Detected	5784	TS22_organ system	46	4.769468e-1	1.000000e+0	1.000000e+0	2.096670e+0	4.769468e-1	1	4.769468e-1	1.000000e+0	47	4.454434e-1	1.000000e+0	1.000000e+0	1.958424e+0	5.106147e-1	1	4606	5.000000e-1	2.171081e-4	unnamed	LARS2
MGI Expression: Detected	7005	TS28_brain	47	4.776274e-1	1.000000e+0	1.000000e+0	2.093682e+0	4.776274e-1	1	4.776274e-1	1.000000e+0	49	4.562057e-1	1.000000e+0	1.000000e+0	1.904264e+0	5.251372e-1	1	4737	5.000000e-1	2.111041e-4	unnamed	TMEM158
MGI Expression: Detected	7003	TS28_central nervous system	48	4.961740e-1	1.000000e+0	1.000000e+0	2.015422e+0	4.961740e-1	1	4.961740e-1	1.000000e+0	50	4.783750e-1	1.000000e+0	1.000000e+0	1.800140e+0	5.555124e-1	1	5011	5.000000e-1	1.995610e-4	unnamed	TMEM158
MGI Expression: Detected	7001	TS28_nervous system	49	4.974351e-1	1.000000e+0	1.000000e+0	2.010313e+0	4.974351e-1	1	4.974351e-1	1.000000e+0	51	4.798952e-1	1.000000e+0	1.000000e+0	1.793340e+0	5.576188e-1	1	5030	5.000000e-1	1.988072e-4	unnamed	TMEM158
MGI Expression: Detected	5741	TS22_embryo	50	5.012384e-1	1.000000e+0	1.000000e+0	1.995059e+0	5.012384e-1	1	5.012384e-1	1.000000e+0	7	7.591070e-2	1.000000e+0	1.000000e+0	3.629250e+0	5.510781e-1	2	4971	1.000000e+0	4.023335e-4	unnamed	LARS2,TMEM158
MGI Expression: Detected	5740	Theiler_stage_22	51	5.025708e-1	1.000000e+0	1.000000e+0	1.989769e+0	5.025708e-1	1	5.025708e-1	1.000000e+0	8	7.664554e-2	1.000000e+0	1.000000e+0	3.611812e+0	5.537387e-1	2	4995	1.000000e+0	4.004004e-4	unnamed	LARS2,TMEM158
MGI Expression: Detected	6944	TS28_organ system	52	6.191523e-1	1.000000e+0	1.000000e+0	1.615112e+0	6.191523e-1	1	6.191523e-1	1.000000e+0	52	6.326325e-1	1.000000e+0	1.000000e+0	1.269420e+0	7.877612e-1	1	7106	5.000000e-1	1.407261e-4	unnamed	TMEM158
MGI Expression: Detected	6937	TS28_postnatal mouse	53	6.225233e-1	1.000000e+0	1.000000e+0	1.606366e+0	6.225233e-1	1	6.225233e-1	1.000000e+0	53	6.373878e-1	1.000000e+0	1.000000e+0	1.256862e+0	7.956322e-1	1	7177	5.000000e-1	1.393340e-4	unnamed	TMEM158
MSigDB Perturbation	VALK_AML_CLUSTER_8	Top 40 genes from cluster 8 of aculte myeloid leukemia (AML) expression profile; 69% of the samples are FAB M2 subtype.	1	3.083555e-3	1.000000e+0	1.000000e+0	3.243010e+2	3.083555e-3	1	3.083555e-3	1.000000e+0	1	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	TMEM158
MSigDB Perturbation	KYNG_DNA_DAMAGE_BY_4NQO	Genes specifically responding to 4NQO treatment of primary fibroblasts.	2	3.755116e-3	1.000000e+0	1.000000e+0	2.663034e+2	3.755116e-3	1	3.755116e-3	1.000000e+0	3	4.097676e-3	1.000000e+0	1.000000e+0	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	TMEM158
MSigDB Perturbation	DASU_IL6_SIGNALING_SCAR_UP	Genes up-regulated in hypertrophic scar fibroblasts in response to IL6 [GeneID=3569].	3	4.030841e-3	1.000000e+0	1.000000e+0	2.480872e+2	4.030841e-3	1	4.030841e-3	1.000000e+0	2	3.323085e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	TMEM158
MSigDB Perturbation	DASU_IL6_SIGNALING_UP	Genes up-regulated in normal fibroblasts in response to IL6 [GeneID=3569].	4	4.802916e-3	1.000000e+0	1.000000e+0	2.082068e+2	4.802916e-3	1	4.802916e-3	1.000000e+0	5	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	TMEM158
MSigDB Perturbation	GALE_APL_WITH_FLT3_MUTATED_UP	Genes up-regulated in acute promyelocytic leukemia (APL) patients with mutated FLT3 [GeneID=2322].	5	5.582893e-3	1.000000e+0	1.000000e+0	1.791186e+2	5.582893e-3	1	5.582893e-3	1.000000e+0	4	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	LARS2
MSigDB Perturbation	ELVIDGE_HIF1A_TARGETS_UP	Genes up-regulated in MCF7 cells (breast cancer) after knockdown of HIF1A [GeneID=3091] by RNAi.	6	6.103924e-3	1.000000e+0	1.000000e+0	1.638290e+2	6.103924e-3	1	6.103924e-3	1.000000e+0	7	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	LARS2
MSigDB Perturbation	COLDREN_GEFITINIB_RESISTANCE_UP	Genes up-regulated in NSCLC (non-small cell lung carcinoma) cell lines resistant to gefitinib [PubChem=123631] compared to the sensitive ones.	7	7.334566e-3	1.000000e+0	1.000000e+0	1.363407e+2	7.334566e-3	1	7.334566e-3	1.000000e+0	10	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	TMEM158
MSigDB Perturbation	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	Genes up-regulated in MDA-MB-231 cells (breast cancer, mutated TP53 [GeneID=7157]) undergoing mitotic arrest and apoptosis after treatment with 100 nM docetaxel [PubChem=148124].	8	8.105674e-3	1.000000e+0	1.000000e+0	1.233704e+2	8.105674e-3	1	8.105674e-3	1.000000e+0	8	8.186938e-3	1.000000e+0	1.000000e+0	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	TMEM158
MSigDB Perturbation	BILANGES_SERUM_SENSITIVE_GENES	Genes translationally regulated in MEF cells (embryonic fibroblasts) in response to serum starvation but not by rapamycin (sirolimus) [PubChemID=6610346].	9	8.577273e-3	1.000000e+0	1.000000e+0	1.165872e+2	8.577273e-3	1	8.577273e-3	1.000000e+0	13	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	LARS2
MSigDB Perturbation	RADMACHER_AML_PROGNOSIS	The 'Bullinger validation signature' [PMID=15084693] used to validate prediction of prognostic outcome of acute myeloid leukemia (AML) patients with a normal karyotype.	10	1.011658e-2	1.000000e+0	1.000000e+0	9.884765e+1	1.011658e-2	1	1.011658e-2	1.000000e+0	9	8.518131e-3	1.000000e+0	1.000000e+0	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	TMEM158
MSigDB Perturbation	ELVIDGE_HYPOXIA_DN	Genes down-regulated in MCF7 cells (breast cancer) under hypoxia conditions.	11	1.043214e-2	1.000000e+0	1.000000e+0	9.585759e+1	1.043214e-2	1	1.043214e-2	1.000000e+0	20	1.612031e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	LARS2
MSigDB Perturbation	KANG_IMMORTALIZED_BY_TERT_UP	Up-regulated genes in the signature of adipose stromal cells (ADSC) immortalized by forced expression of telomerase (TERT) [GeneID=7015].	12	1.063824e-2	1.000000e+0	1.000000e+0	9.400053e+1	1.063824e-2	1	1.063824e-2	1.000000e+0	15	1.006297e-2	1.000000e+0	1.000000e+0	9.912637e+1	1.008813e-2	1	91	5.000000e-1	1.098901e-2	unnamed	LARS2
MSigDB Perturbation	ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE	Genes in the 'mesenchymal transition signature' common to all invasive cancer types.	13	1.065411e-2	1.000000e+0	1.000000e+0	9.386046e+1	1.065411e-2	1	1.065411e-2	1.000000e+0	6	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	TMEM158
MSigDB Perturbation	LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	Genes up-regulated between two breast carcinoma subtypes: metaplastic (MCB) and ductal (DCB).	14	1.116177e-2	1.000000e+0	1.000000e+0	8.959151e+1	1.116177e-2	1	1.116177e-2	1.000000e+0	11	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	TMEM158
MSigDB Perturbation	GAVIN_FOXP3_TARGETS_CLUSTER_P7	Cluster P7 of genes with similar expression profiles in peripheral T lymphocytes after FOXP3 [GeneID=50943] loss of function (LOF).	15	1.136702e-2	1.000000e+0	1.000000e+0	8.797377e+1	1.136702e-2	1	1.136702e-2	1.000000e+0	12	9.401043e-3	1.000000e+0	1.000000e+0	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	TMEM158
MSigDB Perturbation	TIEN_INTESTINE_PROBIOTICS_2HR_DN	Genes down-regulated in Caco-2 cells (intestinal epithelium) after coculture with the probiotic bacteria L. casei for 2h.	16	1.138529e-2	1.000000e+0	1.000000e+0	8.783263e+1	1.138529e-2	1	1.138529e-2	1.000000e+0	13	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	LARS2
MSigDB Perturbation	ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	Genes up-regulated in 3 out of 4 NSCLC cell lines (non-small cell lung cancer) after treatment with azacitidine [PubChem=9444] and TSA [PubChem=5562].	17	1.422442e-2	1.000000e+0	1.000000e+0	7.030165e+1	1.422442e-2	1	1.422442e-2	1.000000e+0	27	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	TMEM158
MSigDB Perturbation	KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	Genes changed in U373-MG cells (malignant glioma) upon treatment with arsenic trioxide [PubChem=14888], a chemical that can cause autophagic cell death.	18	1.448054e-2	1.000000e+0	1.000000e+0	6.905821e+1	1.448054e-2	1	1.448054e-2	1.000000e+0	17	1.336928e-2	1.000000e+0	1.000000e+0	7.454959e+1	1.341389e-2	1	121	5.000000e-1	8.264463e-3	unnamed	TMEM158
MSigDB Perturbation	AMIT_EGF_RESPONSE_480_HELA	Genes whose expression peaked at 480 min after stimulation of HeLa cells with EGF [GeneID=1950].	19	1.494327e-2	1.000000e+0	1.000000e+0	6.691976e+1	1.494327e-2	1	1.494327e-2	1.000000e+0	22	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	TMEM158
MSigDB Perturbation	BROWNE_HCMV_INFECTION_20HR_DN	Genes down-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 20 h time point that were not down-regulated at the previous time point, 18 h.	20	1.542731e-2	1.000000e+0	1.000000e+0	6.482011e+1	1.542731e-2	1	1.542731e-2	1.000000e+0	16	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	TMEM158
MSigDB Perturbation	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	Genes up-regulated in monocytes by RUNX1-RUNX1T1 [GeneID=861;862] fusion.	21	1.693383e-2	1.000000e+0	1.000000e+0	5.905338e+1	1.693383e-2	1	1.693383e-2	1.000000e+0	28	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	TMEM158
MSigDB Perturbation	LIU_SOX4_TARGETS_UP	Genes up-regulated in LNCaP cells (prostate cancer) by overexpression of SOX4 [GeneID=6659] and down-regulated by its RNAi knockdown.	22	1.698269e-2	1.000000e+0	1.000000e+0	5.888350e+1	1.698269e-2	1	1.698269e-2	1.000000e+0	18	1.480029e-2	1.000000e+0	1.000000e+0	6.731716e+1	1.485505e-2	1	134	5.000000e-1	7.462687e-3	unnamed	TMEM158
MSigDB Perturbation	RUIZ_TNC_TARGETS_DN	Genes down-regulated in T98G cells (glioblastoma) by TNC [GeneID=3371].	23	1.700761e-2	1.000000e+0	1.000000e+0	5.879722e+1	1.700761e-2	1	1.700761e-2	1.000000e+0	19	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	TMEM158
MSigDB Perturbation	TIEN_INTESTINE_PROBIOTICS_6HR_DN	Genes down-regulated in Caco-2 cells (intestinal epithelium) after coculture with the probiotic bacteria L. casei for 6h.	24	2.009742e-2	1.000000e+0	1.000000e+0	4.975762e+1	2.009742e-2	1	2.009742e-2	1.000000e+0	21	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	LARS2
MSigDB Perturbation	KYNG_DNA_DAMAGE_DN	Genes with GO annotation and down-regulated after DNA damage in cell lines from young donors.	25	2.064042e-2	1.000000e+0	1.000000e+0	4.844862e+1	2.064042e-2	1	2.064042e-2	1.000000e+0	26	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	TMEM158
MSigDB Perturbation	KOBAYASHI_EGFR_SIGNALING_24HR_DN	Genes down-regulated in H1975 cells (non-small cell lung cancer, NSCLC) resistant to gefitinib [PubChem=123631] after treatment with EGFR inhibitor CL-387785 [PubChem=2776] for 24h.	26	2.179460e-2	1.000000e+0	1.000000e+0	4.588292e+1	2.179460e-2	1	2.179460e-2	1.000000e+0	33	2.894409e-2	1.000000e+0	1.000000e+0	3.429848e+1	2.915581e-2	1	263	5.000000e-1	3.802281e-3	unnamed	TMEM158
MSigDB Perturbation	LI_INDUCED_T_TO_NATURAL_KILLER_UP	Genes up-regulated in ITNK cells (T-lymphocyte progenitors (DN3 cells) reprogrammed to natural killer (NK) cells by ablation of BCL11B [GeneID=64919] gene), compared to the parental DN3 cells.	27	2.276746e-2	1.000000e+0	1.000000e+0	4.392234e+1	2.276746e-2	1	2.276746e-2	1.000000e+0	36	3.232775e-2	1.000000e+0	1.000000e+0	3.068197e+1	3.259243e-2	1	294	5.000000e-1	3.401361e-3	unnamed	TMEM158
MSigDB Perturbation	LEI_MYB_TARGETS	Myb-regulated genes in MCF7 (breast cancer) and lung epithelial cell lines overexpressing MYBL2, MYBL1 or MYB [GeneID=4605;4603;4602].	28	2.437585e-2	1.000000e+0	1.000000e+0	4.102422e+1	2.437585e-2	1	2.437585e-2	1.000000e+0	38	3.439869e-2	1.000000e+0	1.000000e+0	2.881949e+1	3.469874e-2	1	313	5.000000e-1	3.194888e-3	unnamed	TMEM158
MSigDB Perturbation	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	Genes down-regulated in SH-SY5Y cells (neuroblastoma) after treatment with epoxomicin [PubChem=3035402], a protease inhibitor causing apoptosis.	29	2.505742e-2	1.000000e+0	1.000000e+0	3.990833e+1	2.505742e-2	1	2.505742e-2	1.000000e+0	24	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	TMEM158
MSigDB Perturbation	YAGI_AML_FAB_MARKERS	Genes specifically expressed in FAB subtypes M2, M4, M5 and M7 of pediatric AML (acute myeloid leukemia).	30	2.534588e-2	1.000000e+0	1.000000e+0	3.945414e+1	2.534588e-2	1	2.534588e-2	1.000000e+0	25	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	LARS2
MSigDB Perturbation	BILD_E2F3_ONCOGENIC_SIGNATURE	Genes selected in supervised analyses to discriminate cells expressing E2F3 [GeneID=1871] from control cells expressing GFP.	31	2.600043e-2	1.000000e+0	1.000000e+0	3.846091e+1	2.600043e-2	1	2.600043e-2	1.000000e+0	31	2.533565e-2	1.000000e+0	1.000000e+0	3.921957e+1	2.549748e-2	1	230	5.000000e-1	4.347826e-3	unnamed	TMEM158
MSigDB Perturbation	WALLACE_PROSTATE_CANCER_RACE_UP	Genes up-regulated in prostate cancer samples from African-American patients compared to those from the European-American patients.	32	2.937598e-2	1.000000e+0	1.000000e+0	3.404142e+1	2.937598e-2	1	2.937598e-2	1.000000e+0	35	3.080038e-2	1.000000e+0	1.000000e+0	3.221607e+1	3.104041e-2	1	280	5.000000e-1	3.571429e-3	unnamed	TMEM158
MSigDB Perturbation	SENESE_HDAC1_AND_HDAC2_TARGETS_UP	Genes up-regulated in U2OS cells (osteosarcoma) upon knockdown of both HDAC1 and HDAC2 [GeneID=3065;3066] by RNAi.	33	3.024238e-2	1.000000e+0	1.000000e+0	3.306618e+1	3.024238e-2	1	3.024238e-2	1.000000e+0	30	2.467884e-2	1.000000e+0	1.000000e+0	4.027009e+1	2.483233e-2	1	224	5.000000e-1	4.464286e-3	unnamed	TMEM158
MSigDB Perturbation	RIGGI_EWING_SARCOMA_PROGENITOR_DN	Genes down-regulated in mesenchymal stem cells (MSC) engineered to express EWS-FLI1 [GeneID=2130;2321] fusion protein.	34	3.031015e-2	1.000000e+0	1.000000e+0	3.299225e+1	3.031015e-2	1	3.031015e-2	1.000000e+0	23	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	TMEM158
MSigDB Perturbation	MOOTHA_HUMAN_MITODB_6_2002	Mitochondrial genes; based on literature and sequence annotation resources and converted to Affymetrix HG-U133A probe sets.	35	3.082442e-2	1.000000e+0	1.000000e+0	3.244181e+1	3.082442e-2	1	3.082442e-2	1.000000e+0	50	4.710240e-2	1.000000e+0	1.000000e+0	2.097791e+1	4.766920e-2	1	430	5.000000e-1	2.325581e-3	unnamed	LARS2
MSigDB Perturbation	MOOTHA_MITOCHONDRIA	Mitochondrial genes	36	3.109557e-2	1.000000e+0	1.000000e+0	3.215893e+1	3.109557e-2	1	3.109557e-2	1.000000e+0	53	4.904935e-2	1.000000e+0	1.000000e+0	2.013504e+1	4.966465e-2	1	448	5.000000e-1	2.232143e-3	unnamed	LARS2
MSigDB Perturbation	LIM_MAMMARY_STEM_CELL_DN	Genes consistently down-regulated in mammary stem cells both in mouse and human species.	37	3.226078e-2	1.000000e+0	1.000000e+0	3.099739e+1	3.226078e-2	1	3.226078e-2	1.000000e+0	47	4.591162e-2	1.000000e+0	1.000000e+0	2.152864e+1	4.644975e-2	1	419	5.000000e-1	2.386635e-3	unnamed	TMEM158
MSigDB Perturbation	MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	Genes up-regulated during pubertal mammary gland development between week 4 and 5.	38	3.235801e-2	1.000000e+0	1.000000e+0	3.090425e+1	3.235801e-2	1	3.235801e-2	1.000000e+0	34	2.905334e-2	1.000000e+0	1.000000e+0	3.416856e+1	2.926667e-2	1	264	5.000000e-1	3.787879e-3	unnamed	TMEM158
MSigDB Perturbation	VECCHI_GASTRIC_CANCER_EARLY_UP	Up-regulated genes distinguishing between early gastric cancer (EGC) and normal tissue samples.	39	3.247479e-2	1.000000e+0	1.000000e+0	3.079312e+1	3.247479e-2	1	3.247479e-2	1.000000e+0	46	4.352782e-2	1.000000e+0	1.000000e+0	2.272166e+1	4.401086e-2	1	397	5.000000e-1	2.518892e-3	unnamed	TMEM158
MSigDB Perturbation	SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	Genes down-regulated in bone relapse of breast cancer.	40	3.400917e-2	1.000000e+0	1.000000e+0	2.940383e+1	3.400917e-2	1	3.400917e-2	1.000000e+0	37	3.276392e-2	1.000000e+0	1.000000e+0	3.027013e+1	3.303586e-2	1	298	5.000000e-1	3.355705e-3	unnamed	TMEM158
MSigDB Perturbation	VERHAAK_AML_WITH_NPM1_MUTATED_DN	Genes down-regulated in acute myeloid leukemia (AML) patients with mutated NPM1 [GeneID=4869].	41	3.430012e-2	1.000000e+0	1.000000e+0	2.915442e+1	3.430012e-2	1	3.430012e-2	1.000000e+0	32	2.697668e-2	1.000000e+0	1.000000e+0	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	TMEM158
MSigDB Perturbation	GARY_CD5_TARGETS_DN	Genes down-regulated in Daudi cells (B lymphocytes) stably expressing CD5 [GeneID=921] off a plasmid vector.	42	3.783698e-2	1.000000e+0	1.000000e+0	2.642917e+1	3.783698e-2	1	3.783698e-2	1.000000e+0	48	4.612818e-2	1.000000e+0	1.000000e+0	2.142637e+1	4.667147e-2	1	421	5.000000e-1	2.375297e-3	unnamed	LARS2
MSigDB Perturbation	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	Genes commonly down-regulated in UET-13 cells (mesenchymal progenitor) by expression of EWSR1 [GeneID=2130] fusions with ETS transcription factors FLI1 and ERG [GeneID=2313 ,2078].	43	4.168651e-2	1.000000e+0	1.000000e+0	2.398858e+1	4.168651e-2	1	4.168651e-2	1.000000e+0	29	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	TMEM158
MSigDB Perturbation	FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	Genes which best discriminate between two groups of breast cancer according the status of ESR1 and AR [GeneID=2099;367]: apocrine (ESR1- AR+) vs basal (ESR1- AR-).	44	4.240436e-2	1.000000e+0	1.000000e+0	2.358248e+1	4.240436e-2	1	4.240436e-2	1.000000e+0	39	3.516110e-2	1.000000e+0	1.000000e+0	2.818906e+1	3.547475e-2	1	320	5.000000e-1	3.125000e-3	unnamed	TMEM158
MSigDB Perturbation	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	Genes up-regulated in ME-A cells (breast cancer, sensitive to apoptotic stimuli) exposed to doxorubicin [PubChem=31703] in the presence of medium concentrate (MC) from ME-C cells (breast cancer, resistant to apoptotic stimuli).	45	4.262412e-2	1.000000e+0	1.000000e+0	2.346089e+1	4.262412e-2	1	4.262412e-2	1.000000e+0	62	6.519651e-2	1.000000e+0	1.000000e+0	1.508445e+1	6.629344e-2	1	598	5.000000e-1	1.672241e-3	unnamed	TMEM158
MSigDB Perturbation	PHONG_TNF_RESPONSE_NOT_VIA_P38	Genes whose expression changes in Calu-6 cells (lung cancer) by TNF [GeneID=7124] were not affected by p38 inhibitor LY479754.	46	4.385350e-2	1.000000e+0	1.000000e+0	2.280320e+1	4.385350e-2	1	4.385350e-2	1.000000e+0	40	3.657622e-2	1.000000e+0	1.000000e+0	2.708859e+1	3.691591e-2	1	333	5.000000e-1	3.003003e-3	unnamed	TMEM158
MSigDB Perturbation	KOYAMA_SEMA3B_TARGETS_DN	Genes down-regulated in NCI-H1299 cells (large cell neuroendocrine carcinoma) stably expressing SEMA3B [GeneID=7869].	47	4.388800e-2	1.000000e+0	1.000000e+0	2.278527e+1	4.388800e-2	1	4.388800e-2	1.000000e+0	42	4.103249e-2	1.000000e+0	1.000000e+0	2.411898e+1	4.146112e-2	1	374	5.000000e-1	2.673797e-3	unnamed	TMEM158
MSigDB Perturbation	TIEN_INTESTINE_PROBIOTICS_24HR_UP	Genes up-regulated in Caco-2 cells (intestinal epithelium) after coculture with the probiotic bacteria L. casei for 24h.	48	4.577476e-2	1.000000e+0	1.000000e+0	2.184610e+1	4.577476e-2	1	4.577476e-2	1.000000e+0	61	5.972199e-2	1.000000e+0	1.000000e+0	1.649086e+1	6.063965e-2	1	547	5.000000e-1	1.828154e-3	unnamed	LARS2
MSigDB Perturbation	HAN_SATB1_TARGETS_UP	Genes up-regulated in MDA-MB-231 cells (breast cancer) after knockdown of SATB1 [GeneID=6304] by RNAi.	49	4.593672e-2	1.000000e+0	1.000000e+0	2.176908e+1	4.593672e-2	1	4.593672e-2	1.000000e+0	44	4.190080e-2	1.000000e+0	1.000000e+0	2.361387e+1	4.234799e-2	1	382	5.000000e-1	2.617801e-3	unnamed	TMEM158
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_2B	Genes specifically up-regulated in Cluster IIb of urothelial cell carcinom (UCC) tumors.	50	4.661543e-2	1.000000e+0	1.000000e+0	2.145212e+1	4.661543e-2	1	4.661543e-2	1.000000e+0	43	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	TMEM158
MSigDB Perturbation	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	Transcripts depleted from pseudopodia of NIH/3T3 cells (fibroblast) in response to haptotactic migratory stimulus by fibronectin, FN1 [GeneID=2335].	51	5.127776e-2	1.000000e+0	1.000000e+0	1.950163e+1	5.127776e-2	1	5.127776e-2	1.000000e+0	64	7.161666e-2	1.000000e+0	1.000000e+0	1.370897e+1	7.294496e-2	1	658	5.000000e-1	1.519757e-3	unnamed	TMEM158
MSigDB Perturbation	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	Genes with copy number losses in primary neuroblastoma tumors.	52	5.143070e-2	1.000000e+0	1.000000e+0	1.944364e+1	5.143070e-2	1	5.143070e-2	1.000000e+0	67	8.035509e-2	1.000000e+0	1.000000e+0	1.218986e+1	8.203536e-2	1	740	5.000000e-1	1.351351e-3	unnamed	LARS2
MSigDB Perturbation	HAN_SATB1_TARGETS_DN	Genes down-regulated in MDA-MB-231 cells (breast cancer) after knockdown of SATB1 [GeneID=6304] by RNAi.	53	5.266731e-2	1.000000e+0	1.000000e+0	1.898711e+1	5.266731e-2	1	5.266731e-2	1.000000e+0	49	4.688595e-2	1.000000e+0	1.000000e+0	2.107593e+1	4.744748e-2	1	428	5.000000e-1	2.336449e-3	unnamed	TMEM158
MSigDB Perturbation	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	Genes up-regulated in invasive ductal carcinoma (IDC) relative to ductal carcinoma in situ (DCIS, non-invasive).	54	5.284057e-2	1.000000e+0	1.000000e+0	1.892485e+1	5.284057e-2	1	5.284057e-2	1.000000e+0	41	3.799030e-2	1.000000e+0	1.000000e+0	2.607081e+1	3.835708e-2	1	346	5.000000e-1	2.890173e-3	unnamed	TMEM158
MSigDB Perturbation	SENESE_HDAC1_TARGETS_UP	Genes up-regulated in U2OS cells (osteosarcoma) upon knockdown of HDAC1 [GeneID=3065] by RNAi.	55	5.286044e-2	1.000000e+0	1.000000e+0	1.891774e+1	5.286044e-2	1	5.286044e-2	1.000000e+0	51	4.721062e-2	1.000000e+0	1.000000e+0	2.092923e+1	4.778006e-2	1	431	5.000000e-1	2.320186e-3	unnamed	TMEM158
MSigDB Perturbation	PILON_KLF1_TARGETS_UP	Genes up-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	56	5.387062e-2	1.000000e+0	1.000000e+0	1.856299e+1	5.387062e-2	1	5.387062e-2	1.000000e+0	56	5.347664e-2	1.000000e+0	1.000000e+0	1.844683e+1	5.420986e-2	1	489	5.000000e-1	2.044990e-3	unnamed	TMEM158
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	Genes up-regulated in ME-A cells (breast cancer) undergoing apoptosis upon serum starvation (5% to 0% FCS) for 22 hr.	57	5.536438e-2	1.000000e+0	1.000000e+0	1.806215e+1	5.536438e-2	1	5.536438e-2	1.000000e+0	58	5.886179e-2	1.000000e+0	1.000000e+0	1.673562e+1	5.975279e-2	1	539	5.000000e-1	1.855288e-3	unnamed	TMEM158
MSigDB Perturbation	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	Genes up-regulated in nasopharyngeal carcinoma (NPC) positive for LMP1 [GeneID=9260], a latent gene of Epstein-Barr virus (EBV).	58	5.992122e-2	1.000000e+0	1.000000e+0	1.668858e+1	5.992122e-2	1	5.992122e-2	1.000000e+0	44	4.190080e-2	1.000000e+0	1.000000e+0	2.361387e+1	4.234799e-2	1	382	5.000000e-1	2.617801e-3	unnamed	TMEM158
MSigDB Perturbation	KIM_ALL_DISORDERS_CALB1_CORR_UP	Genes whose expression significantly and positively correlated with the density of CALB1-positive [GeneID=793]  GABAergic interneurons in the BA9 brain region across all subjects with psychiatric disorders.	59	6.127712e-2	1.000000e+0	1.000000e+0	1.631931e+1	6.127712e-2	1	6.127712e-2	1.000000e+0	60	5.939946e-2	1.000000e+0	1.000000e+0	1.658180e+1	6.030708e-2	1	544	5.000000e-1	1.838235e-3	unnamed	TMEM158
MSigDB Perturbation	SMID_BREAST_CANCER_LUMINAL_B_DN	Genes down-regulated in the luminal B subtype of breast cancer.	60	6.137749e-2	1.000000e+0	1.000000e+0	1.629262e+1	6.137749e-2	1	6.137749e-2	1.000000e+0	59	5.918441e-2	1.000000e+0	1.000000e+0	1.664299e+1	6.008536e-2	1	542	5.000000e-1	1.845018e-3	unnamed	TMEM158
MSigDB Perturbation	ONKEN_UVEAL_MELANOMA_DN	Genes down-regulated in uveal melanoma: class 2 vs class 1 tumors.	61	6.267829e-2	1.000000e+0	1.000000e+0	1.595449e+1	6.267829e-2	1	6.267829e-2	1.000000e+0	57	5.574028e-2	1.000000e+0	1.000000e+0	1.768725e+1	5.653789e-2	1	510	5.000000e-1	1.960784e-3	unnamed	LARS2
MSigDB Perturbation	CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	Genes down-regulated in luminal-like breast cancer cell lines compared to the mesenchymal-like ones.	62	6.453439e-2	1.000000e+0	1.000000e+0	1.549561e+1	6.453439e-2	1	6.453439e-2	1.000000e+0	52	4.883312e-2	1.000000e+0	1.000000e+0	2.022534e+1	4.944294e-2	1	446	5.000000e-1	2.242152e-3	unnamed	TMEM158
MSigDB Perturbation	SENESE_HDAC3_TARGETS_UP	Genes up-regulated in U2OS cells (osteosarcoma) upon knockdown of HDAC3 [GeneID=8841] by RNAi.	63	6.886261e-2	1.000000e+0	1.000000e+0	1.452167e+1	6.886261e-2	1	6.886261e-2	1.000000e+0	54	5.207398e-2	1.000000e+0	1.000000e+0	1.895063e+1	5.276869e-2	1	476	5.000000e-1	2.100840e-3	unnamed	TMEM158
MSigDB Perturbation	SMID_BREAST_CANCER_BASAL_UP	Genes up-regulated in basal subtype of breast cancer samles.	64	7.093597e-2	1.000000e+0	1.000000e+0	1.409722e+1	7.093597e-2	1	7.093597e-2	1.000000e+0	63	6.840935e-2	1.000000e+0	1.000000e+0	1.436385e+1	6.961920e-2	1	628	5.000000e-1	1.592357e-3	unnamed	TMEM158
MSigDB Perturbation	FORTSCHEGGER_PHF8_TARGETS_DN	Genes down-regulated in HeLa cells (cervical carcinoma) upon knockdown of PHF8 [GeneID=23133] by RNAi.	65	7.444945e-2	1.000000e+0	1.000000e+0	1.343193e+1	7.444945e-2	1	7.444945e-2	1.000000e+0	68	8.109914e-2	1.000000e+0	1.000000e+0	1.207564e+1	8.281137e-2	1	747	5.000000e-1	1.338688e-3	unnamed	TMEM158
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	Genes up-regulated in ME-A cells (breast cancer) undergoing apoptosis in response to doxorubicin [PubChem=31703].	66	7.551862e-2	1.000000e+0	1.000000e+0	1.324177e+1	7.551862e-2	1	7.551862e-2	1.000000e+0	72	1.189586e-1	1.000000e+0	1.000000e+0	8.148600e+0	1.227205e-1	1	1107	5.000000e-1	9.033424e-4	unnamed	TMEM158
MSigDB Perturbation	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	Genes up-regulated in anaplastic thyroid carcinoma (ATC) compared to normal thyroid tissue.	67	7.606396e-2	1.000000e+0	1.000000e+0	1.314683e+1	7.606396e-2	1	7.606396e-2	1.000000e+0	65	7.694989e-2	1.000000e+0	1.000000e+0	1.274082e+1	7.848789e-2	1	708	5.000000e-1	1.412429e-3	unnamed	TMEM158
MSigDB Perturbation	NUYTTEN_NIPP1_TARGETS_UP	Genes up-regulated in PC3 cells (prostate cancer) after knockdown of NIPP1 [GeneID=5511] by RNAi.	68	8.459132e-2	1.000000e+0	1.000000e+0	1.182154e+1	8.459132e-2	1	8.459132e-2	1.000000e+0	66	8.014245e-2	1.000000e+0	1.000000e+0	1.222290e+1	8.181365e-2	1	738	5.000000e-1	1.355014e-3	unnamed	TMEM158
MSigDB Perturbation	NUYTTEN_EZH2_TARGETS_DN	Genes down-regulated in PC3 cells (prostate cancer) after knockdown of EZH2 [GeneID=2146] by RNAi.	69	8.521044e-2	1.000000e+0	1.000000e+0	1.173565e+1	8.521044e-2	1	8.521044e-2	1.000000e+0	71	1.056935e-1	1.000000e+0	1.000000e+0	9.204592e+0	1.086414e-1	1	980	5.000000e-1	1.020408e-3	unnamed	LARS2
MSigDB Perturbation	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	Common down-regulated transcripts in fibroblasts expressing either XP/CS or TDD mutant forms of ERCC3 [GeneID=2071], after UVC irradiation.	70	8.562533e-2	1.000000e+0	1.000000e+0	1.167879e+1	8.562533e-2	1	8.562533e-2	1.000000e+0	55	5.228984e-2	1.000000e+0	1.000000e+0	1.887134e+1	5.299041e-2	1	478	5.000000e-1	2.092050e-3	unnamed	LARS2
MSigDB Perturbation	ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN	Genes whose DNA is hyper-methylated in hepatocellular carcinoma (HCC) compared to normal liver.	71	1.007221e-1	1.000000e+0	1.000000e+0	9.928311e+0	1.007221e-1	1	1.007221e-1	1.000000e+0	69	8.460275e-2	1.000000e+0	1.000000e+0	1.156474e+1	8.646971e-2	1	780	5.000000e-1	1.282051e-3	unnamed	LARS2
MSigDB Perturbation	PUJANA_BRCA1_PCC_NETWORK	Genes constituting the BRCA1-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA1 [GeneID=672] across a compendium of normal tissues.	72	1.292550e-1	1.000000e+0	1.000000e+0	7.736644e+0	1.292550e-1	1	1.292550e-1	1.000000e+0	73	1.731460e-1	1.000000e+0	1.000000e+0	5.513753e+0	1.813647e-1	1	1636	5.000000e-1	6.112469e-4	unnamed	LARS2
MSigDB Perturbation	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	Genes down-regulated in fibroblasts expressing mutant forms of ERCC3 [GeneID=2071] after UV irradiation.	73	1.422357e-1	1.000000e+0	1.000000e+0	7.030586e+0	1.422357e-1	1	1.422357e-1	1.000000e+0	70	9.095579e-2	1.000000e+0	1.000000e+0	1.073869e+1	9.312122e-2	1	840	5.000000e-1	1.190476e-3	unnamed	LARS2
MSigDB Predicted Promoter Motifs	V$E2A_Q2	Motif NCACCTGYYNCNKN matches TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	1	2.671256e-2	1.000000e+0	1.000000e+0	3.743557e+1	2.671256e-2	1	2.671256e-2	1.000000e+0	1	2.544509e-2	1.000000e+0	1.000000e+0	3.904978e+1	2.560834e-2	1	231	5.000000e-1	4.329004e-3	unnamed	LARS2
MSigDB Predicted Promoter Motifs	AAAYRNCTG_UNKNOWN	Motif AAAYRNCTG (no known TF)	2	5.602604e-2	1.000000e+0	1.000000e+0	1.784884e+1	5.602604e-2	1	5.602604e-2	1.000000e+0	2	3.864260e-2	1.000000e+0	1.000000e+0	2.562642e+1	3.902223e-2	1	352	5.000000e-1	2.840909e-3	unnamed	LARS2
InterPro	IPR002302	Leucine-tRNA ligase, bacterial/mitochondrial	1	1.253185e-4	1.000000e+0	1.000000e+0	7.979668e+3	1.253185e-4	1	1.253185e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	LARS2
InterPro	IPR015413	Methionyl/Leucyl tRNA synthetase	2	2.647943e-4	1.000000e+0	1.000000e+0	3.776516e+3	2.647943e-4	1	2.647943e-4	1.000000e+0	2	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	LARS2
InterPro	IPR002300	Aminoacyl-tRNA synthetase, class Ia	3	3.657135e-4	1.000000e+0	1.000000e+0	2.734381e+3	3.657135e-4	1	3.657135e-4	1.000000e+0	3	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	LARS2
InterPro	IPR009008	Valyl/Leucyl/Isoleucyl-tRNA synthetase, editing domain	3	3.657135e-4	1.000000e+0	1.000000e+0	2.734381e+3	3.657135e-4	1	3.657135e-4	1.000000e+0	3	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	LARS2
InterPro	IPR013155	Valyl/Leucyl/Isoleucyl-tRNA synthetase, class I, anticodon-binding	3	3.657135e-4	1.000000e+0	1.000000e+0	2.734381e+3	3.657135e-4	1	3.657135e-4	1.000000e+0	3	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	LARS2
InterPro	IPR009080	Aminoacyl-tRNA synthetase, class 1a, anticodon-binding	6	6.342382e-4	1.000000e+0	9.959654e-1	1.576695e+3	6.342382e-4	1	6.342382e-4	1.000000e+0	6	1.440682e-3	1.000000e+0	1.000000e+0	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	LARS2
InterPro	IPR001412	Aminoacyl-tRNA synthetase, class I, conserved site	7	8.794701e-4	1.000000e+0	1.000000e+0	1.137048e+3	8.794701e-4	1	8.794701e-4	1.000000e+0	7	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	LARS2
InterPro	IPR014729	Rossmann-like alpha/beta/alpha sandwich fold	8	3.026337e-3	1.000000e+0	1.000000e+0	3.304324e+2	3.026337e-3	1	3.026337e-3	1.000000e+0	8	4.650770e-3	1.000000e+0	1.000000e+0	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	LARS2
TreeFam	TF339241	TMEM158	1	8.112886e-5	6.592531e-1	6.592531e-1	1.232607e+4	8.112886e-5	1	8.112886e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	TMEM158
TreeFam	TF105662	leucyl-tRNA synthetase 2, mitochondrial	2	1.253185e-4	1.000000e+0	5.091691e-1	7.979668e+3	1.253185e-4	1	1.253185e-4	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	LARS2
HGNC Gene Families	AARS1	AARS1	1	9.714557e-4	4.643558e-1	4.643558e-1	1.029383e+3	9.714557e-4	1	9.714557e-4	1.000000e+0	1	1.994515e-3	9.533782e-1	9.533782e-1	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	LARS2
Ensembl Genes	13427	TMEM158	1	8.112886e-5	1.000000e+0	1.000000e+0	1.232607e+4	8.112886e-5	1	8.112886e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	TMEM158
Ensembl Genes	13428	LARS2	2	1.253185e-4	1.000000e+0	1.000000e+0	7.979668e+3	1.253185e-4	1	1.253185e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	LARS2
MSigDB Oncogenic Signatures	PDGF_UP.V1_UP	Genes up-regulated in SH-SY5Y cells (neuroblastoma) in response to PDGF [Gene ID=] stimulation.	1	1.184223e-2	1.000000e+0	1.000000e+0	8.444355e+1	1.184223e-2	1	1.184223e-2	1.000000e+0	4	1.535041e-2	1.000000e+0	7.176317e-1	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	TMEM158
MSigDB Oncogenic Signatures	NRL_DN.V1_DN	Genes down-regulated in retina cells from NRL [Gene ID=4901] knockout mice.	2	1.317478e-2	1.000000e+0	1.000000e+0	7.590257e+1	1.317478e-2	1	1.317478e-2	1.000000e+0	2	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	TMEM158
MSigDB Oncogenic Signatures	RPS14_DN.V1_DN	Genes down-regulated in CD34+ hematopoietic progenitor cells after knockdown of RPS14 [Gene ID=6208] by RNAi.	3	1.454501e-2	1.000000e+0	9.066390e-1	6.875211e+1	1.454501e-2	1	1.454501e-2	1.000000e+0	9	2.029452e-2	1.000000e+0	4.216750e-1	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	LARS2
MSigDB Oncogenic Signatures	KRAS.LUNG_UP.V1_UP	Genes up-regulated in epithelial lung cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	4	1.543884e-2	1.000000e+0	7.217658e-1	6.477171e+1	1.543884e-2	1	1.543884e-2	1.000000e+0	3	1.447015e-2	1.000000e+0	9.019727e-1	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	TMEM158
MSigDB Oncogenic Signatures	E2F3_UP.V1_UP	Genes up-regulated in primary epithelial breast cancer cell culture over-expressing E2F3 [Gene ID=1871] gene.	5	1.634156e-2	1.000000e+0	6.111743e-1	6.119368e+1	1.634156e-2	1	1.634156e-2	1.000000e+0	6	1.941648e-2	1.000000e+0	6.051470e-1	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	TMEM158
MSigDB Oncogenic Signatures	CRX_NRL_DN.V1_DN	Genes down-regulated in retina cells from CRX and NRL [Gene ID=1406, 4901] double knockout mice.	6	1.639008e-2	1.000000e+0	5.108242e-1	6.101250e+1	1.639008e-2	1	1.639008e-2	1.000000e+0	1	1.369960e-2	1.000000e+0	1.000000e+0	7.274597e+1	1.374647e-2	1	124	5.000000e-1	8.064516e-3	unnamed	TMEM158
MSigDB Oncogenic Signatures	IL15_UP.V1_UP	Genes up-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL15 [Gene ID=3600].	7	1.731437e-2	1.000000e+0	4.625410e-1	5.775551e+1	1.731437e-2	1	1.731437e-2	1.000000e+0	7	1.963603e-2	1.000000e+0	5.245625e-1	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	TMEM158
MSigDB Oncogenic Signatures	PIGF_UP.V1_DN	Genes down-regulated in HUVEC cells (endothelium) by treatment with PIGF [Gene ID=5281].	8	1.839052e-2	1.000000e+0	4.298784e-1	5.437585e+1	1.839052e-2	1	1.839052e-2	1.000000e+0	10	2.040425e-2	1.000000e+0	3.815595e-1	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	TMEM158
MSigDB Oncogenic Signatures	ESC_V6.5_UP_EARLY.V1_UP	Genes up-regulated during early stages of differentiation of embryoid bodies from V6.5 embryonic stem cells.	9	1.863725e-2	1.000000e+0	3.872406e-1	5.365599e+1	1.863725e-2	1	1.863725e-2	1.000000e+0	5	1.831837e-2	1.000000e+0	6.851070e-1	5.434036e+1	1.840253e-2	1	166	5.000000e-1	6.024096e-3	unnamed	TMEM158
MSigDB Oncogenic Signatures	MTOR_UP.N4.V1_UP	Genes up-regulated in CEM-C1 cells (T-CLL) by everolimus [PubChem = 6442177], an mTOR pathway inhibitor.	10	1.881809e-2	1.000000e+0	3.518983e-1	5.314036e+1	1.881809e-2	1	1.881809e-2	1.000000e+0	12	2.150119e-2	1.000000e+0	3.350602e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	LARS2
MSigDB Oncogenic Signatures	IL2_UP.V1_UP	Genes up-regulated in Sez-4 cells (T lymphocyte) that were first starved of IL2 [Gene ID=3558] and then stimulated with IL2 [Gene ID=3558].	11	1.893527e-2	1.000000e+0	3.218996e-1	5.281151e+1	1.893527e-2	1	1.893527e-2	1.000000e+0	8	1.974579e-2	1.000000e+0	4.615578e-1	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	TMEM158
MSigDB Oncogenic Signatures	KRAS.DF.V1_UP	Genes up-regulated in epithelial lung cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	12	2.141496e-2	1.000000e+0	3.337165e-1	4.669632e+1	2.141496e-2	1	2.141496e-2	1.000000e+0	11	2.084310e-2	1.000000e+0	3.543327e-1	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	TMEM158
MSigDB Oncogenic Signatures	LEF1_UP.V1_UP	Genes up-regulated in DLD1 cells (colon carcinoma) over-expressing LEF1 [Gene ID=51176].	13	2.313259e-2	1.000000e+0	3.327534e-1	4.322906e+1	2.313259e-2	1	2.313259e-2	1.000000e+0	12	2.150119e-2	1.000000e+0	3.350602e-1	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	TMEM158
MSigDB Oncogenic Signatures	KRAS.600.LUNG.BREAST_UP.V1_UP	Genes up-regulated in epithelial lung and breast cancer cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	14	3.169326e-2	1.000000e+0	4.233314e-1	3.155245e+1	3.169326e-2	1	3.169326e-2	1.000000e+0	15	2.949024e-2	1.000000e+0	3.676450e-1	3.365858e+1	2.971010e-2	1	268	5.000000e-1	3.731343e-3	unnamed	TMEM158
MSigDB Oncogenic Signatures	KRAS.600_UP.V1_UP	Genes up-regulated in four lineages of epithelial cell lines over-expressing an oncogenic form of KRAS [Gene ID=3845] gene.	15	4.035466e-2	1.000000e+0	5.030881e-1	2.478028e+1	4.035466e-2	1	4.035466e-2	1.000000e+0	14	2.916257e-2	1.000000e+0	3.895286e-1	3.403962e+1	2.937753e-2	1	265	5.000000e-1	3.773585e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN	Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 5.	1	1.187574e-2	1.000000e+0	1.000000e+0	8.420530e+1	1.187574e-2	1	1.187574e-2	1.000000e+0	34	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	LARS2
MSigDB Immunologic Signatures	GSE3982_NEUTROPHIL_VS_BASOPHIL_UP	Genes up-regulated in comparison of neutrophils versus basophils.	2	1.416540e-2	1.000000e+0	1.000000e+0	7.059454e+1	1.416540e-2	1	1.416540e-2	1.000000e+0	6	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN	Genes down-regulated in comparison of unstimulated memory CD4 [GeneID=920] CD8 T cells versus stimulated CD4 [GeneID=920] CD8 T cells.	3	1.447164e-2	1.000000e+0	1.000000e+0	6.910068e+1	1.447164e-2	1	1.447164e-2	1.000000e+0	34	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	LARS2
MSigDB Immunologic Signatures	GSE10325_BCELL_VS_LUPUS_BCELL_UP	Genes up-regulated in comparison of healthy B cells versus systemic lupus erythematosus B cells.	4	1.475708e-2	1.000000e+0	1.000000e+0	6.776409e+1	1.475708e-2	1	1.475708e-2	1.000000e+0	5	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus resting regulatory T cell (Treg).	5	1.489314e-2	1.000000e+0	1.000000e+0	6.714501e+1	1.489314e-2	1	1.489314e-2	1.000000e+0	3	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_6H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 6 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 6 h.	6	1.492250e-2	1.000000e+0	1.000000e+0	6.701289e+1	1.492250e-2	1	1.492250e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN	Genes down-regulated in comparison of microglia cells 6 h after stimulation with IFNG [GeneID=3458] versus microglia cells 24 h after the stimulation.	7	1.500117e-2	1.000000e+0	1.000000e+0	6.666145e+1	1.500117e-2	1	1.500117e-2	1.000000e+0	27	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	LARS2
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN	Genes down-regulated in comparison of myeloid dendritic cells (mDC) from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	8	1.526745e-2	1.000000e+0	1.000000e+0	6.549883e+1	1.526745e-2	1	1.526745e-2	1.000000e+0	10	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	LARS2
MSigDB Immunologic Signatures	GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worm/well B. malayi versus macrophages exposed to 5 worms/well B. malayi.	9	1.543044e-2	1.000000e+0	1.000000e+0	6.480697e+1	1.543044e-2	1	1.543044e-2	1.000000e+0	34	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to 5 worms/well B. malayi versus DC exposed to M. tuberculosis	10	1.574861e-2	1.000000e+0	1.000000e+0	6.349765e+1	1.574861e-2	1	1.574861e-2	1.000000e+0	38	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN	Genes down-regulated in comparison of resting regulatory T cell (Treg) versus non-suppressive T cells.	11	1.583711e-2	1.000000e+0	1.000000e+0	6.314284e+1	1.583711e-2	1	1.583711e-2	1.000000e+0	13	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE17580_TREG_VS_TEFF_UP	Genes up-regulated in comparison of regulatory T cell (Treg) from uninfected mice versus T effector cells from uninfected mice.	12	1.656600e-2	1.000000e+0	1.000000e+0	6.036462e+1	1.656600e-2	1	1.656600e-2	1.000000e+0	16	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN	Genes down-regulated in comparison of PTPRC- [GeneID=5788] CD4 [GeneID=920] T cells versus non-suppressive T cells.	13	1.659577e-2	1.000000e+0	1.000000e+0	6.025632e+1	1.659577e-2	1	1.659577e-2	1.000000e+0	16	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE27786_NKTCELL_VS_MONO_MAC_DN	Genes down-regulated in comparison of NKT cells versus monocyte macrophages.	14	1.677996e-2	1.000000e+0	1.000000e+0	5.959490e+1	1.677996e-2	1	1.677996e-2	1.000000e+0	34	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_BCELL_DN	Genes down-regulated in comparison of eosinophils versus B cells.	15	1.678553e-2	1.000000e+0	1.000000e+0	5.957512e+1	1.678553e-2	1	1.678553e-2	1.000000e+0	7	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	LARS2
MSigDB Immunologic Signatures	GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) exposed to 50 worms/well B. malayi versus DC exposed to M. tuberculosis	16	1.743973e-2	1.000000e+0	1.000000e+0	5.734033e+1	1.743973e-2	1	1.743973e-2	1.000000e+0	27	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE13306_RA_VS_UNTREATED_TREG_UP	Genes up-regulated in comparison of regulatory T cell (Treg) treated with retinoic acid (tretinoin) [PubChem=444795] versus untreated regulatory T cell (Treg).	17	1.786180e-2	1.000000e+0	1.000000e+0	5.598541e+1	1.786180e-2	1	1.786180e-2	1.000000e+0	7	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus activated regulatory T cell (Treg).	18	1.808587e-2	1.000000e+0	1.000000e+0	5.529177e+1	1.808587e-2	1	1.808587e-2	1.000000e+0	10	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE15767_MED_VS_SCS_MAC_LN_DN	Genes down-regulated in comparison of medullary macrophages versus subcapsular sinus (SCS) macrophages.	19	1.838685e-2	1.000000e+0	1.000000e+0	5.438668e+1	1.838685e-2	1	1.838685e-2	1.000000e+0	20	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE27786_LSK_VS_NKTCELL_UP	Genes up-regulated in comparison of LSK versus NKT cells.	20	1.839024e-2	1.000000e+0	1.000000e+0	5.437667e+1	1.839024e-2	1	1.839024e-2	1.000000e+0	20	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus non-suppressive T cells.	21	1.848952e-2	1.000000e+0	1.000000e+0	5.408470e+1	1.848952e-2	1	1.848952e-2	1.000000e+0	7	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN	Genes down-regulated in comparison of Ctrlrv versus Foxp3rv (see Fig. 1 in the paper for details).	22	1.853709e-2	1.000000e+0	1.000000e+0	5.394590e+1	1.853709e-2	1	1.853709e-2	1.000000e+0	20	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN	Genes down-regulated in comparison of Jurkat T cells stimulated in the presence of PD-1 versus controls.	23	1.856682e-2	1.000000e+0	1.000000e+0	5.385952e+1	1.856682e-2	1	1.856682e-2	1.000000e+0	20	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	LARS2
MSigDB Immunologic Signatures	GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 6 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 6 h.	24	1.863532e-2	1.000000e+0	1.000000e+0	5.366155e+1	1.863532e-2	1	1.863532e-2	1.000000e+0	31	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN	Genes down-regulated in comparison of plasmacytoid dendritic cells (DC) from influenza vaccinee at day 0 versus myeloid DCs at day 7 post-vaccination.	25	1.866727e-2	1.000000e+0	1.000000e+0	5.356970e+1	1.866727e-2	1	1.866727e-2	1.000000e+0	13	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	LARS2
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP	Genes up-regulated in comparison of plasmacytoid dendritic cells (pDC) from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	26	1.880230e-2	1.000000e+0	1.000000e+0	5.318498e+1	1.880230e-2	1	1.880230e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP	Genes up-regulated in comparison of monocytes from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	27	1.895971e-2	1.000000e+0	1.000000e+0	5.274341e+1	1.895971e-2	1	1.895971e-2	1.000000e+0	20	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_CPG_6H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 6 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 6 h.	28	1.913437e-2	1.000000e+0	1.000000e+0	5.226198e+1	1.913437e-2	1	1.913437e-2	1.000000e+0	31	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP	Genes up-regulated in comparison of TregLP versus TconvLP (see Table 1S in the paper for details).	29	2.036164e-2	1.000000e+0	1.000000e+0	4.911197e+1	2.036164e-2	1	2.036164e-2	1.000000e+0	10	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP	Genes up-regulated in comparison of regulatory T cell (Treg) from mice infected with S. mansoni versus T effector cells from the infected mice.	30	2.057634e-2	1.000000e+0	1.000000e+0	4.859951e+1	2.057634e-2	1	2.057634e-2	1.000000e+0	38	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP	Genes up-regulated in comparison of myeloid dendritic cells (mDC) from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	31	2.126595e-2	1.000000e+0	1.000000e+0	4.702352e+1	2.126595e-2	1	2.126595e-2	1.000000e+0	3	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE7852_TREG_VS_TCONV_UP	Genes up-regulated in comparison of regulatory T cells versus conventional T cells.	32	2.213058e-2	1.000000e+0	1.000000e+0	4.518634e+1	2.213058e-2	1	2.213058e-2	1.000000e+0	20	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 6 h versus the untreated cells at 6 h.	33	2.217003e-2	1.000000e+0	1.000000e+0	4.510595e+1	2.217003e-2	1	2.217003e-2	1.000000e+0	1	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN	Genes down-regulated in comparsion of ActCD8 versus ActCD4 (see Fig. 1 in the paper for details).	34	2.285833e-2	1.000000e+0	1.000000e+0	4.374773e+1	2.285833e-2	1	2.285833e-2	1.000000e+0	27	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	LARS2
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus CD4 [GeneID=920] CD8 thymocytes.	35	2.334868e-2	1.000000e+0	1.000000e+0	4.282898e+1	2.334868e-2	1	2.334868e-2	1.000000e+0	13	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	LARS2
MSigDB Immunologic Signatures	GSE7460_TCONV_VS_TREG_LN_DN	Genes down-regulated in comparison of TconvLN versus TregLN (see Fig. 1 in the paper for details).	36	2.424482e-2	1.000000e+0	1.000000e+0	4.124592e+1	2.424482e-2	1	2.424482e-2	1.000000e+0	27	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE7852_TREG_VS_TCONV_LN_UP	Genes up-regulated in comparison of lymph node regulatory T cells versus lymph node conventional T cells.	37	2.491028e-2	1.000000e+0	1.000000e+0	4.014407e+1	2.491028e-2	1	2.491028e-2	1.000000e+0	20	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	TMEM158
MSigDB Immunologic Signatures	GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] T cells treated with IL4 [GeneID=3565] and anti-IL12 at 12 h versus the untreated cells at 12 h.	38	2.576867e-2	1.000000e+0	1.000000e+0	3.880681e+1	2.576867e-2	1	2.576867e-2	1.000000e+0	2	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	LARS2
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN	Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus thymic stromal cells.	39	2.716302e-2	1.000000e+0	1.000000e+0	3.681475e+1	2.716302e-2	1	2.716302e-2	1.000000e+0	31	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	TMEM158
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
